
  
    
      
        Background_NNP
        Microglia_NNP are_VBP leukocytes_NNS derived_VBN outside_IN the_DT central_JJ
        nervous_JJ system_NN in_IN the_DT bone_NN marrow_NN ,_, from_IN where_WRB they_PRP enter_VBP
        the_DT circulation_NN as_IN monocytes_NNS and_CC migrate_VB into_IN the_DT brain_NN
        during_IN late_JJ embryonic_JJ life_NN establishing_VBG permanent_JJ residency_NN
        [_NN 1_CD ]_NN ._. Two_CD different_JJ phenotypic_JJ forms_NNS of_IN microglia_NN are_VBP
        known_VBN :_: the_DT activated_VBN but_CC nonphagocytic_JJ microglia_NN ,_, which_WDT
        play_VBP a_DT role_NN in_IN inflammatory_JJ pathologies_NNS ,_, and_CC the_DT reactive_JJ
        or_CC phagocytic_JJ microglia_NN which_WDT participate_VBP actively_RB in_IN
        trauma_NN ,_, infection_NN and_CC neuronal_NN degeneration_NN [_NN 2_CD ]_NN ._.
        
        In_IN vivo_NN as_RB well_RB as_IN 
        in_IN vitro_NN administration_NN of_IN LPS_NNP
        rapidly_RB and_CC potently_RB activates_NNS rat_NN adult_NN and_CC neonatal_NN
        microglia_NN (_( for_IN review_NN see_VB Ref_NNP ._. [_NN 3_CD ]_NN )_) ._. Accompanying_NNP both_DT
        adult_NN and_CC neonatal_NN microglia_NN activation_NN by_IN LPS_NNP [_NN 4_CD ]_NN is_VBZ a_DT
        concomitant_NN release_NN of_IN numerous_JJ secretory_NN products_NNS (_( for_IN
        review_NN see_VB Ref_NNP ._. [_NN 3_CD ]_NN )_) that_WDT include_VBP tissue_NN plasminogen_NN
        activator_NN [_NN 5_CD ]_NN ,_, reactive_JJ oxygen_NN species_NNS such_JJ as_IN O_NNP 
        2_CD -_: [_NN 6_CD 7_CD ]_NN ,_, cytokines_NNS like_IN TNF-α_NNP [_NN 7_CD 8_CD
        ]_NN and_CC proteases_NNS ,_, in_IN particular_JJ MMP-_NNP 9_CD [_NN 7_CD 9_CD ]_NN ,_, in_IN a_DT time-_NN
        and_CC concentration-dependent_JJ manner_NN ._. These_DT mediators_NNS have_VBP
        been_VBN implicated_VBN in_IN sublethal_NN and_CC lethal_JJ neuronal_NN and_CC glial_NN
        injury_NN [_NN 10_CD ]_NN ,_, neuronal_NN degeneration_NN [_NN 3_CD 11_CD 12_CD ]_NN that_WDT
        could_MD potentially_RB affect_VB neurodevelopment_NN in_IN the_DT immature_NN
        brain_NN ._.
        Exposure_NNP to_TO the_DT marine_JJ toxin_NN domoic_JJ acid_NN ,_, an_DT excitotoxic_JJ
        amino_JJ acid_NN structurally_RB similar_JJ to_TO kainic_JJ acid_NN and_CC to_TO the_DT
        neurotransmitter_NN glutamic_JJ acid_NN ,_, has_VBZ been_VBN shown_VBN to_TO lead_VB to_TO
        amnesic_JJ shellfish_NN poisoning_NN in_IN humans_NNS ,_, a_DT condition_NN that_WDT can_MD
        lead_VB to_TO death_NN in_IN extreme_JJ cases_NNS [_NN 13_CD ]_NN ._. Currently_RB ,_, the_DT
        Center_NNP for_IN Food_NNP Safety_NNP and_CC Applied_NNP Nutrition_NNP ,_, US_NNP ._. Food_NNP and_CC
        Drug_NNP Administration_NNP has_VBZ included_VBN amnesic_JJ shellfish_NN
        poisoning_NN as_IN one_CD of_IN the_DT "_'' 
        ._. ._. ._. five_CD recognized_VBN fish_NN poisoning_NN
        syndromes_NNS in_IN the_DT United_NNP States_NNPS ._. ._. ._. "_'' ,_, together_RB with_IN
        paralytic_JJ ,_, neurotoxic_JJ ,_, diarrhetic_JJ and_CC ciguatera_NN fish_NN
        poisoning_NN (_( FDA_NNP website_NN :_:
        http_NN :_: /_NN /_NN vm_NN ._. cfsan_NN ._. fda_NN ._. gov_NN /_NN ~_NN dms_NNS /_NN haccp-_NN 2_CD f_SYM ._. html_NN )_) [_NN 14_CD ]_NN ._. Recent_JJ
        behavioral_JJ toxicity_NN studies_NNS in_IN rodents_NNS ,_, have_VBP confirmed_VBN that_IN
        domoic_JJ acid_NN is_VBZ a_DT very_RB rapid_JJ and_CC potent_JJ neurotoxin_NN in_IN
        newborn_JJ rats_NNS ,_, at_IN doses_NNS far_RB lower_JJR than_IN in_IN adult_NN animals_NNS [_NN 15_CD
        16_CD 17_CD ]_NN ._. Even_RB though_IN hippocampal_NN pyramidal_NN neurons_NNS and_CC
        mossy_NN fiber_NN terminals_NNS appear_VBP to_TO be_VB selectively_RB targeted_VBN 
        in_IN vivo_NN by_IN domoic_JJ acid_NN in_IN rat_NN [_NN 18_CD ]_NN
        and_CC cynomolgus_JJ monkey_NN brain_NN [_NN 19_CD ]_NN ,_, recently_RB domoic_JJ acid_NN
        was_VBD shown_VBN to_TO affect_VB glutamate_NN uptake_NN by_IN astrocytes_NNS 
        in_IN vitro_NN and_CC "_'' 
        ._. ._. ._. thus_RB produced_VBN neurotoxicity_NN ._. ._. ._. "_'' [_NN
        20_CD ]_NN ._. Of_IN interest_NN is_VBZ the_DT fact_NN that_IN no_DT studies_NNS to_TO our_PRP$
        knowledge_NN have_VBP investigated_VBN the_DT potential_JJ contribution_NN of_IN
        brain_NN microglia_NN to_TO neonatal_NN neurotoxicity_NN after_IN a_DT
        short-term_JJ exposure_NN to_TO domoic_JJ acid_NN [_NN 21_CD ]_NN ._.
        The_DT possibility_NN that_IN domoic_JJ acid_NN may_MD activate_VBP neonatal_NN
        microglia_NN both_DT 
        in_IN vitro_NN and_CC 
        in_IN vivo_NN is_VBZ suggested_VBN by_IN recent_JJ
        observations_NNS with_IN kainic_JJ acid_NN ,_, a_DT domoic_JJ acid_NN and_CC glutamate_NN
        analog_NN that_WDT can_MD induce_VB upregulation_NN of_IN neonatal_NN microglia_NN
        scavenger_NN receptor_NN mRNA_NN [_NN 22_CD ]_NN and_CC tissue_NN plasminogen_NN
        activator_NN release_NN [_NN 23_CD ]_NN ._. The_DT putative_JJ molecular_JJ
        explanation_NN for_IN these_DT observations_NNS has_VBZ been_VBN that_IN kainic_JJ
        acid_NN activates_NNS the_DT ionotropic_JJ AMPA_NNP glutamate_NN GluR_NNP 4_CD subunit_NN
        which_WDT has_VBZ recently_RB been_VBN shown_VBN to_TO be_VB expressed_VBN by_IN activated_VBN
        microglia_NN following_VBG transient_JJ forebrain_NN ischemia_NN 
        in_IN vivo_NN [_NN 24_CD ]_NN ._. Because_IN this_DT subunit_NN
        of_IN the_DT AMPA_NNP glutamate_NN receptor_NN has_VBZ affinity_NN for_IN domoic_JJ acid_NN
        [_NN 25_CD 26_CD 27_CD ]_NN ,_, we_PRP hypothesized_VBN that_IN domoic_JJ acid_NN might_MD
        activate_VBP neonatal_NN microglia_NN 
        in_IN vitro_NN and_CC lead_VB to_TO concomitant_NN
        mediator_NN release_NN [_NN 21_CD ]_NN ._.
        The_DT purpose_NN of_IN this_DT investigation_NN was_VBD to_TO determine_VB if_IN a_DT
        short-term_JJ 
        in_IN vitro_NN exposure_NN to_TO domoic_JJ acid_NN
        might_MD activate_VBP rat_VB neonatal_NN microglia_NN and_CC cause_VB mediator_NN
        release_NN ._. Using_VBG LPS_NNP ,_, which_WDT we_PRP have_VBP previously_RB shown_VBN is_VBZ a_DT
        rapid_JJ and_CC potent_JJ 
        in_IN vitro_NN activator_NN of_IN neonatal_NN
        microglia_NN [_NN 7_CD ]_NN as_IN our_PRP$ positive_JJ control_NN ,_, we_PRP focused_VBD our_PRP$
        investigation_NN on_IN three_CD microglia_NN mediators_NNS which_WDT are_VBP
        released_VBN upon_IN LPS_NNP activation_NN ,_, namely_RB TNF-α_NNP ,_, MMP-_NNP 9_CD and_CC O_NNP 
        2_CD -_: [_NN 7_CD ]_NN ._. Our_PRP$ present_JJ study_NN
        demonstrates_VBZ that_IN in_IN contrast_NN to_TO LPS_NNP ,_, during_IN a_DT 6_CD hour_NN 
        in_IN vitro_NN exposure_NN to_TO domoic_JJ acid_NN ,_,
        neonatal_NN rat_NN microglia_NN release_NN small_JJ ,_, but_CC statistically_RB
        significant_JJ amounts_NNS of_IN TNF-α_NNP and_CC MMP-_NNP 9_CD ._. Furthermore_RB our_PRP$
        observations_NNS suggest_VBP that_IN 
        in_IN vivo_NN ,_, brain_NN microglia_NN as_RB well_RB as_IN
        the_DT mediators_NNS released_VBN by_IN this_DT cell_NN type_NN in_IN brain_NN tissue_NN ,_,
        would_MD appear_VB to_TO play_VB a_DT limited_JJ role_NN in_IN the_DT rapid_JJ and_CC potent_JJ
        domoic_JJ acid_NN neurotoxicity_NN observed_VBD in_IN neonatal_NN rats_NNS after_IN a_DT
        short-term_JJ administration_NN of_IN domoic_JJ acid_NN ._.
      
      
        Results_NNS
        
          Determination_NNP of_IN domoic_JJ acid_NN by_IN electrospray_NN mass_NN
          spectrometry_NN
          The_DT presence_NN of_IN undegraded_JJ domoic_JJ acid_NN in_IN both_DT stock_NN
          solution_NN (_( 12_CD ._. 5_LS mM_NN )_) and_CC dilutions_NNS prepared_VBN with_IN LPS-free_NNP
          water_NN was_VBD confirmed_VBN by_IN electrospray_NN mass_NN spectrometry_NN
          prior_RB to_TO the_DT experiments_NNS ._. As_IN shown_VBN for_IN the_DT 12_CD ._. 5_LS mM_NN domoic_JJ
          acid_NN stock_NN solution_NN in_IN Fig_NNP ._. 1_LS A_DT ,_, the_DT dominate_VB ion_NN in_IN the_DT
          spectrum_NN was_VBD 
          m_NN /_NN z_SYM 312_CD ._. 2_LS which_WDT is_VBZ the_DT
          pseudomolecular_NN ion_NN [_NN M_NNP +_NN H_NNP ]_NN +_NN of_IN domoic_JJ acid_NN ._. Also_RB present_JJ
          in_IN the_DT spectrum_NN were_VBD 
          m_NN /_NN z_SYM 334_CD ._. 2_LS ,_, the_DT sodium_NN adduct_NN [_NN M_NNP +_NN Na_NNP ]_NN
          +_NN of_IN domoic_JJ acid_NN ,_, 
          m_NN /_NN z_SYM 623_CD ._. 3_LS ,_, the_DT dimer_NN [_NN 2_CD M_NNP +_NN H_NNP ]_NN +_NN of_IN
          domoic_JJ acid_NN ,_, and_CC 
          m_NN /_NN z_SYM 645_CD ._. 4_LS [_NN 2_CD M_NNP +_NN Na_NNP ]_NN +_NN ,_, the_DT sodium_NN
          adduct_NN of_IN the_DT dimer_NN ._. The_DT dimer_NN was_VBD formed_VBN in_IN the_DT gas_NN
          phase_NN due_JJ to_TO the_DT high_JJ concentration_NN of_IN the_DT sample_NN ._. Mass_NNP
          spectra_NN for_IN dilution_NN of_IN 2_CD ._. 5_CD ,_, 0_CD ._. 25_CD and_CC 0_CD ._. 025_CD mM_NN also_RB
          showed_VBD as_IN the_DT dominate_VB ion_NN 
          m_NN /_NN z_SYM 312_CD ,_, domoic_JJ acid_NN [_NN M_NNP +_NN H_NNP ]_NN +_NN (_( data_NNS
          not_RB shown_VBN )_) ._. As_IN shown_VBN in_IN Fig_NNP ._. 1_LS B_NNP ,_, for_IN the_DT lowest_JJS domoic_JJ
          acid_NN concentration_NN used_VBN in_IN our_PRP$ studies_NNS ,_, namely_RB 0_CD ._. 0025_CD mM_NN
          domoic_JJ acid_NN ,_, although_IN background_NN noise_NN dominated_VBD the_DT
          sample_NN ,_, 
          m_NN /_NN z_SYM 312_CD ._. 2_LS ,_, the_DT domoic_JJ acid_NN [_NN M_NNP +_NN H_NNP ]_NN
          +_NN was_VBD clearly_RB seen_VBN in_IN the_DT spectrum_NN ._.
        
        
          Immunofluorescent_NNP visualization_NN of_IN CD_NNP 11_CD b_SYM /_NN c_SYM and_CC
          glutamate_NN receptor_NN subunit_NN GluR_NNP 4_CD in_IN rat_NN neonatal_NN
          microglia_NN
          It_PRP has_VBZ recently_RB been_VBN reported_VBN that_IN transient_JJ forebrain_NN
          ischemia_NN leads_VBZ to_TO the_DT expression_NN of_IN the_DT inotropic_JJ AMPA_NNP
          glutamate_NN receptor_NN GluR_NNP 4_CD subunit_NN 
          in_IN vivo_NN [_NN 24_CD ]_NN in_IN rat_NN neonatal_NN
          microglia_NN ._. In_IN order_NN to_TO ascertain_VB that_IN under_IN our_PRP$
          experimental_JJ conditions_NNS rat_NN neonatal_NN microglia_NN expressed_VBD
          the_DT GluR_NNP 4_CD subunit_NN ,_, we_PRP studied_VBD the_DT expression_NN of_IN the_DT AMPA_NNP
          receptor_NN GluR_NNP 4_CD by_IN immunohistochemistry_NN ._. The_DT top_NN left_JJ
          photo_NN in_IN Fig_NNP ._. 2_LS shows_VBZ a_DT bright_JJ field_NN ,_, phase_NN contrast_NN view_NN
          of_IN microglia_NN that_WDT were_VBD incubated_JJ in_IN the_DT absence_NN of_IN the_DT
          primary_JJ antibodies_NNS against_IN GluR_NNP 4_CD and_CC CD_NNP 11_CD b_SYM /_NN c_SYM ._. Note_VB that_IN
          the_DT microglia_NN are_VBP irregular_JJ in_IN shape_NN and_CC show_VB numerous_JJ
          elongated_JJ processes_VBZ extending_VBG from_IN the_DT bodies_NNS of_IN the_DT
          cells_NNS ._. In_IN addition_NN ,_, numerous_JJ vesicular_NN structures_NNS are_VBP
          present_JJ in_IN the_DT cytoplasm_NN of_IN the_DT microglia_NN ._. The_DT top_JJ right_JJ
          photo_NN shows_VBZ the_DT same_JJ microglia_NN when_WRB viewed_VBN using_VBG the_DT FITC_NNP
          filter_NN configuration_NN ._. Note_VB that_IN the_DT vesicular_NN structures_NNS
          exhibit_NN an_DT intense_JJ autofluorescence_NN ,_, but_CC that_IN little_JJ or_CC
          no_DT fluorescence_NN is_VBZ evident_JJ over_IN most_JJS of_IN the_DT microglia_NN
          cell_NN bodies_NNS or_CC in_IN the_DT elongated_JJ processes_NNS ._. Interestingly_RB ,_,
          this_DT same_JJ pattern_NN of_IN autofluorescence_NN was_VBD evident_JJ when_WRB
          the_DT microglia_NN were_VBD viewed_VBN with_IN the_DT TRITC_NNP filter_NN
          configuration_NN (_( not_RB shown_VBN )_) ._. The_DT middle_NN left_JJ photo_NN shows_VBZ a_DT
          bright_JJ field_NN ,_, phase_NN contrast_NN view_NN of_IN microglia_NN that_WDT had_VBD
          been_VBN labeled_VBN with_IN the_DT antibodies_NNS against_IN the_DT glutamate_NN
          receptor_NN GluR_NNP 4_CD subunit_NN and_CC the_DT leukocyte_NN marker_NN CD_NNP 11_CD b_SYM /_NN c_SYM ._.
          Again_RB ,_, the_DT microglia_NN are_VBP irregular_JJ in_IN shape_NN ,_, with_IN
          elongated_JJ processes_VBZ extending_VBG from_IN the_DT cell_NN bodies_NNS and_CC
          numerous_JJ vesicles_NNS present_JJ in_IN the_DT cytoplasm_NN ._. The_DT middle_JJ
          right_JJ photo_NN (_( green_JJ )_) shows_VBZ this_DT same_JJ field_NN when_WRB viewed_VBN
          using_VBG the_DT FITC_NNP filter_NN configuration_NN ._. As_IN evident_JJ ,_, the_DT
          microglia_NN not_RB only_RB contain_VB fluorescent_NN vesicles_NNS ,_, but_CC also_RB
          exhibit_VB a_DT prominent_JJ speckled_JJ pattern_NN of_IN fluorescence_NN over_IN
          the_DT cell_NN bodies_NNS and_CC the_DT elongated_JJ processes_NNS ._. The_DT fact_NN
          that_IN this_DT speckled_JJ pattern_NN of_IN labeling_VBG is_VBZ not_RB present_JJ in_IN
          the_DT samples_NNS that_WDT were_VBD incubated_JJ without_IN the_DT primary_JJ GluR_NNP 4_CD
          antibody_NN (_( compare_VB with_IN top_JJ right_JJ photo_NN )_) strongly_RB
          indicates_VBZ that_IN the_DT speckled_JJ pattern_NN represents_VBZ specific_JJ
          labeling_VBG of_IN GluR_NNP 4_CD subunit_NN ._. The_DT lower_JJR left_VBD photo_NN shows_VBZ
          that_IN these_DT same_JJ microglia_NN exhibited_VBN intense_JJ labeling_VBG of_IN
          CD_NNP 11_CD b_SYM /_NN c_SYM (_( red_JJ )_) ,_, which_WDT confirms_VBZ that_IN the_DT microglia_NN are_VBP of_IN
          leukocytic_JJ origin_NN ._. In_IN the_DT bottom_JJ right_JJ photo_NN the_DT images_NNS
          showing_VBG the_DT GluR_NNP 4_CD and_CC the_DT CD_NNP 11_CD b_SYM /_NN c_SYM labeling_VBG have_VBP been_VBN
          superimposed_VBN (_( yellow_JJ )_) ._. Together_RB ,_, these_DT results_NNS indicate_VBP
          that_IN GluR_NNP 4_CD glutamate_NN receptor_NN subunits_NNS are_VBP present_JJ on_IN the_DT
          cell_NN surface_NN and_CC that_IN these_DT cells_NNS are_VBP ,_, in_IN fact_NN ,_,
          microglia_NN ._.
        
        
          Effect_NN of_IN domoic_JJ acid_NN on_IN cerebellar_NN granule_NN cell_NN
          and_CC rat_NN neonatal_NN microglia_NN viability_NN
          Domoic_NNP acid_NN has_VBZ been_VBN reported_VBN to_TO be_VB neurotoxic_JJ to_TO
          neuronal_NN tissue_NN 
          in_IN vitro_NN in_IN concentrations_NNS ranging_VBG
          from_IN 10_CD μM_NN to_TO 20_CD mM_NN [_NN 28_CD 29_CD 30_CD 31_CD 32_CD 33_CD ]_NN ._. In_IN order_NN to_TO
          determine_VB a_DT concentration_NN of_IN domoic_JJ acid_NN that_WDT was_VBD
          neurotoxic_JJ 
          in_IN vitro_NN during_IN a_DT 6_CD hour_NN exposure_NN ,_,
          we_PRP investigated_VBD the_DT concentration-dependent_JJ effect_NN of_IN
          domoic_JJ acid_NN on_IN cerebellar_NN granule_NN neurons_NNS using_VBG the_DT WST-_NNP 1_CD
          viability_NN assay_NN ._. This_DT assay_NN measures_NNS cell_NN viability_NN as_IN a_DT
          function_NN of_IN cleavage_NN of_IN the_DT tetrazolium_NN salt_NN WST-_NNP 1_CD by_IN
          mitochondrial_NN dehydrogenases_NNS in_IN viable_JJ cells_NNS to_TO formazan_NN ._.
          As_IN shown_VBN in_IN Fig_NNP ._. 3_LS Cand_NNP 3_CD Dthe_NNP viability_NN of_IN primary_JJ
          cerebellar_NN granule_NN cells_NNS exposed_VBN for_IN up_IN to_TO 6_CD hours_NNS to_TO
          domoic_JJ acid_NN [_NN 10_CD μM-_NN 1_CD mM_NN ]_NN was_VBD significantly_RB affected_VBN (_( P_NN
          <_NN 0_CD ._. 05_CD )_) ._. In_IN contrast_NN to_TO our_PRP$ observations_NNS with_IN
          cerebellar_NN granule_NN neurons_NNS ,_, domoic_JJ acid_NN even_RB at_IN the_DT
          highest_JJS neurotoxic_JJ concentration_NN tested_VBN in_IN our_PRP$ 
          in_IN vitro_NN study_NN ,_, namely_RB [_NN 1_CD mM_NN ]_NN did_VBD
          not_RB affect_VB microglia_NN viability_NN during_IN a_DT 6_CD hour_NN exposure_NN
          (_( Fig_NNP 3_CD Aand_NNP 3_CD B_NNP )_) ._. Because_IN 1_CD mM_NN domoic_JJ acid_NN was_VBD clearly_RB
          neurotoxic_JJ in_IN our_PRP$ studies_NNS ,_, this_DT concentration_NN was_VBD
          selected_VBN for_IN all_DT 
          in_IN vitro_NN experiments_NNS with_IN
          microglia_NN ._. LPS_NNP (_( 10_CD ng_NN /_NN ml_NN )_) did_VBD not_RB affect_VB microglia_NN
          viability_NN 
          in_IN vitro_NN during_IN a_DT 6_CD hour_NN exposure_NN
          (_( data_NNS not_RB shown_VBN )_) ._.
        
        
          Effect_NN of_IN LPS_NNP and_CC domoic_JJ acid_NN on_IN TNF-α_NNP mRNA_NN
          expression_NN from_IN rat_NN neonatal_NN microglia_NN
          Activation_NNP of_IN microglia_NN has_VBZ been_VBN shown_VBN to_TO cause_VB the_DT
          release_NN of_IN cytokines_NNS such_JJ as_IN TNF-α_NNP [_NN 7_CD 8_CD ]_NN ._. As_IN shown_VBN in_IN
          Fig_NNP ._. 4_LS A_DT ,_, stimulation_NN of_IN microglia_NN with_IN LPS_NNP [_NN 10_CD ng_NN /_NN ml_NN ]_NN
          resulted_VBD in_IN a_DT time-dependent_JJ increase_NN in_IN TNF-α_NNP mRNA_NN
          expression_NN relative_JJ to_TO controls_NNS as_IN determined_VBN by_IN
          semi-quantitative_JJ RT-PCR_NNP at_IN the_DT linear_JJ range_NN of_IN
          amplification_NN (_( 20_CD cycles_NNS )_) ._. Without_IN LPS_NNP treatment_NN
          (_( control_NN )_) ,_, TNF-α_NNP mRNA_NN expression_NN was_VBD undetectable_JJ ._. As_IN
          shown_VBN in_IN Fig_NNP ._. 5_LS ,_, the_DT relative_JJ levels_NNS of_IN TNF-α_NNP expression_NN
          increased_VBD 4_CD ._. 5_CD fold_VB by_IN 1_CD hour_NN and_CC remained_VBD elevated_VBD
          throughout_IN the_DT 6_CD hour_NN observation_NN period_NN ._. In_IN contrast_NN to_TO
          the_DT marked_VBN increase_NN in_IN TNF-α_NNP expression_NN induced_VBN by_IN LPS_NNP ,_,
          as_IN shown_VBN in_IN Fig_NNP ._. 4_LS B_NNP ,_, domoic_JJ acid_NN [_NN 1_CD mM_NN ]_NN induced_VBD a_DT less_RBR
          potent_JJ yet_RB time-dependent_JJ increase_NN in_IN TNF-α_NNP mRNA_NN
          expression_NN as_IN determined_VBN by_IN semi-quantitative_JJ RT-PCR_NNP over_IN
          the_DT linear_JJ range_NN of_IN amplification_NN (_( 25_CD cycles_NNS )_) ._. As_IN shown_VBN
          in_IN Fig_NNP ._. 5_LS ,_, although_IN not_RB statistically_RB significant_JJ ,_, the_DT
          relative_JJ levels_NNS of_IN TNF-α_NNP expression_NN increased_VBN two-fold_JJ by_IN
          4_CD hours_NNS and_CC remained_VBD elevated_VBD during_IN the_DT next_JJ two_CD
          hours_NNS ._.
        
        
          Effect_NN of_IN domoic_JJ acid_NN and_CC LPS_NNP on_IN rat_NN neonatal_NN
          microglia_NN release_NN of_IN TNF-α_NNP
          In_IN order_NN to_TO determine_VB if_IN the_DT increase_NN in_IN TNF-α_NNP mRNA_NN
          after_IN a_DT short_JJ term_NN stimulation_NN with_IN either_DT domoic_JJ acid_NN [_NN 1_CD
          mM_NN ]_NN or_CC LPS_NNP [_NN 10_CD ng_NN /_NN mL_NN ]_NN led_VBN to_TO a_DT concomitant_NN production_NN of_IN
          TNF-α_NNP protein_NN ,_, the_DT cell-free_JJ media_NNS corresponding_JJ to_TO the_DT
          same_JJ microglia_NN used_VBN for_IN TNF-α_NNP mRNA_NN analysis_NN were_VBD assayed_JJ
          with_IN an_DT ultrasensitive_JJ rat-specific_JJ ELISA_NNP ._. As_IN expected_VBN
          and_CC shown_VBN in_IN Fig_NNP ._. 6_CD ,_, LPS_NNP [_NN 10_CD ng_NN /_NN mL_NN ]_NN stimulated_VBN microglia_NN
          time-dependent_JJ TNF-α_NNP release_NN :_: by_IN 4_CD hours_NNS TNF-α_NNP levels_NNS
          increased_VBD 2_CD ,_, 233_CD %_NN and_CC were_VBD 298_CD ._. 7_CD ±_NN 3_CD ._. 9_CD pg_NN /_NN mL_NN
          (_( LPS-treated_NNP ,_, n_NN =_SYM 4_LS )_) vs_NNS ._. 12_CD ._. 8_CD ±_NN 2_CD ._. 6_CD pg_NN /_NN mL_NN (_( untreated_JJ
          controls_NNS ,_, n_NN =_SYM 8_CD )_) ,_, P_NN <_NN 0_CD ._. 01_CD ._. In_IN contrast_NN to_TO LPS_NNP ,_, levels_NNS
          of_IN immunoreactive_JJ TNF-α_NNP in_IN the_DT tissue_NN culture_NN media_NNS
          increased_VBD 53_CD ._. 3_LS %_NN 4_CD hours_NNS after_IN microglia_NN were_VBD treated_VBN
          with_IN domoic_JJ acid_NN [_NN 1_CD mM_NN ]_NN and_CC were_VBD 28_CD ._. 2_LS ±_NN 3_CD ._. 6_CD pg_NN /_NN mL_NN (_( domoic_JJ
          acid-treated_JJ ,_, n_NN =_SYM 6_CD )_) vs_NNS ._. 18_CD ._. 4_LS ±_NN 1_CD ._. 99_CD pg_NN /_NN mL_NN (_( untreated_JJ
          controls_NNS ,_, n_NN =_SYM 10_CD )_) ,_, P_NN <_NN 0_CD ._. 01_CD ._. Interestingly_RB ,_, the_DT 4_CD hour_NN
          time_NN point_NN corresponded_VBD to_TO the_DT highest_JJS level_NN of_IN TNF-α_NNP
          mRNA_NN expression_NN shown_VBN in_IN Fig_NNP ._. 5_LS ._.
        
        
          Effect_NN of_IN domoic_JJ acid_NN and_CC LPS_NNP on_IN rat_NN neonatal_NN
          microglia_NN release_NN of_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD
          We_PRP have_VBP recently_RB shown_VBN that_IN a_DT stimulation_NN of_IN microglia_NN
          with_IN LPS_NNP will_MD lead_VB to_TO both_DT TNF-α_NNP generation_NN and_CC MMP-_NNP 9_CD
          production_NN ,_, a_DT mediator_NN that_WDT has_VBZ been_VBN reported_VBN to_TO be_VB toxic_JJ
          to_TO neuronal_NN tissue_NN [_NN 7_CD ]_NN ._. As_IN shown_VBN in_IN Fig_NNP ._. 7_CD ,_, when_WRB
          microglia_NN were_VBD stimulated_VBN with_IN LPS_NNP [_NN 10_CD ng_NN /_NN mL_NN ]_NN ,_, an_DT
          increase_NN in_IN MMP-_NNP 9_CD and_CC MMP-_NNP 2_CD release_NN was_VBD observed_VBN :_: by_IN 4_CD
          hours_NNS MMP-_NNP 9_CD inverse_NN O_NNP ._. D_NNP ._. levels_NNS increased_VBD 2_CD ,_, 100_CD %_NN and_CC
          were_VBD respectively_RB 0_CD ._. 198_CD ±_NN 0_CD ._. 009_CD (_( LPS-treated_NNP ,_, n_NN =_SYM 3_LS )_) vs_NNS ._.
          0_CD ._. 009_CD ±_NN 0_CD ._. 001_CD (_( untreated_JJ controls_NNS ,_, n_NN =_SYM 3_LS )_) ,_, P_NN <_NN 0_CD ._. 01_CD ._.
          In_IN contrast_NN to_TO LPS_NNP ,_, a_DT 757_CD %_NN increase_NN in_IN MMP-_NNP 9_CD levels_NNS was_VBD
          observed_VBN in_IN the_DT tissue_NN culture_NN media_NNS 4_CD hours_NNS after_IN
          microglia_NN were_VBD treated_VBN with_IN domoic_JJ acid_NN [_NN 1_CD mM_NN ]_NN :_: inverse_NN
          O_NNP ._. D_NNP ._. levels_NNS were_VBD respectively_RB 0_CD ._. 06_CD ±_NN 0_CD ._. 01_CD (_( domoic_JJ
          acid-treated_JJ ,_, n_NN =_SYM 3_LS )_) vs_NNS ._. 0_CD ._. 007_CD ±_NN 0_CD ._. 001_CD (_( untreated_JJ
          controls_NNS ,_, n_NN =_SYM 3_LS )_) ,_, P_NN <_NN 0_CD ._. 01_CD ._. Domoic_NNP acid_NN [_NN 1_CD mM_NN ]_NN had_VBD no_DT
          effect_NN on_IN MMP-_NNP 2_CD release_NN ._.
        
        
          Effect_NN of_IN domoic_JJ acid_NN and_CC LPS_NNP on_IN rat_NN neonatal_NN
          microglia_NN release_NN of_IN O_NNP 2_CD -_:
          We_PRP have_VBP shown_VBN that_IN while_IN unprimed_JJ naive_JJ microglia_NN
          release_NN low_JJ levels_NNS of_IN O_NNP 
          2_CD -_: ,_, pretreatment_NN with_IN LPS_NNP results_NNS in_IN
          an_DT increase_NN of_IN PMA-stimulated_NNP O_NNP 
          2_CD -_: [_NN 7_CD ]_NN ._. As_IN is_VBZ depicted_VBN in_IN Fig_NNP ._. 8_CD A_DT ,_,
          when_WRB microglia_NN were_VBD pretreated_JJ for_IN 6_CD hours_NNS with_IN LPS_NNP [_NN 10_CD
          ng_NN /_NN mL_NN ]_NN ,_, there_EX was_VBD ,_, as_IN expected_VBN ,_, an_DT increase_NN in_IN PMA_NNP [_NN 1_CD
          μM_NN ]_NN -_: stimulated_VBN O_NNP 
          2_CD -_: production_NN :_: 6_CD ._. 5_CD ±_NN 0_CD ._. 9_CD nmoles_NNS /_NN 2_CD
          hours_NNS (_( LPS-pretreated_NNP ,_, n_NN =_SYM 3_LS )_) vs_NNS ._. 1_CD ._. 7_CD ±_NN 0_CD ._. 07_CD nmoles_NNS /_NN 2_CD
          hours_NNS (_( untreated_JJ controls_NNS ,_, n_NN =_SYM 3_LS )_) ,_, P_NN <_NN 0_CD ._. 01_CD ._. In_IN
          contrast_NN ,_, a_DT 6_CD hour_NN pretreatment_NN of_IN microglia_NN with_IN domoic_JJ
          acid_NN [_NN 1_CD mM_NN ]_NN ,_, yielded_VBD no_DT statistically_RB significant_JJ
          increase_NN in_IN PMA_NNP [_NN 1_CD μM_NN ]_NN -_: stimulated_VBN O_NNP 
          2_CD -_: generation_NN :_: 2_CD ._. 97_CD ±_NN 0_CD ._. 44_CD nmoles_NNS /_NN 2_CD
          hours_NNS (_( domoic_JJ acid_NN pretreated_JJ ,_, n_NN =_SYM 3_LS )_) vs_NNS ._. 1_CD ._. 7_CD ±_NN 0_CD ._. 07_CD
          nmoles_NNS /_NN 2_CD hours_NNS (_( untreated_JJ controls_NNS ,_, n_NN =_SYM 3_LS )_) ._. Furthermore_RB ,_,
          domoic_JJ acid_NN did_VBD not_RB affect_VB PMA_NNP [_NN 1_CD μM_NN ]_NN -_: stimulated_VBN O_NNP 
          2_CD -_: generation_NN from_IN 6_CD hour_NN
          LPS-pretreated_NNP microglia_NN :_: 6_CD ._. 5_CD ±_NN 0_CD ._. 9_CD nmoles_NNS /_NN 2_CD hours_NNS
          (_( LPS-pretreated_NNP ,_, n_NN =_SYM 3_LS )_) vs_NNS ._. 6_CD ._. 26_CD ±_NN 0_CD ._. 4_CD nmoles_NNS /_NN 2_CD hours_NNS
          (_( LPS_NNP +_NN domoic_JJ acid_NN pretreated_JJ ,_, n_NN =_SYM 3_LS )_) ._. Finally_RB ,_, as_IN shown_VBN
          in_IN Fig_NNP ._. 8_CD B_NNP ,_, though_IN not_RB statistically_RB significant_JJ ,_, a_DT 2_CD
          hour_NN stimulation_NN with_IN increasing_VBG concentrations_NNS of_IN domoic_JJ
          acid_NN and_CC PMA_NNP [_NN 1_CD μM_NN ]_NN ,_, reduced_VBD O_NNP 
          2_CD -_: generation_NN from_IN 6_CD hours_NNS
          LPS-pretreated_NNP microglia_NN :_: 4_CD ._. 16_CD ±_NN 0_CD ._. 58_CD nmoles_NNS /_NN 2_CD hours_NNS
          (_( domoic_JJ acid_NN [_NN 1_CD mM_NN ]_NN +_NN PMA_NNP [_NN 1_CD μM_NN ]_NN ,_, n_NN =_SYM 3_LS )_) vs_NNS 6_CD ._. 5_CD ±_NN 1_CD ._. 0_CD
          nmoles_NNS /_NN 2_CD hours_NNS (_( untreated_JJ controls_NNS ,_, n_NN =_SYM 3_LS )_) ._.
        
      
      
        Discussion_NNP
        Although_IN domoic_JJ acid_NN 's_POS excitotoxicity_NN to_TO 
        adult_NN neuronal_NN tissue_NN in_IN humans_NNS ,_,
        rats_NNS ,_, mice_NNS and_CC monkeys_NNS is_VBZ well_RB documented_VBN (_( for_IN review_NN see_VB
        Ref_NNP ._. [_NN 21_CD ]_NN )_) ,_, a_DT growing_VBG body_NN of_IN research_NN also_RB suggests_VBZ
        that_IN there_EX might_MD be_VB increased_VBN vulnerability_NN during_IN the_DT 
        neonatal_NN period_NN [_NN 15_CD 16_CD 17_CD ]_NN ._. The_DT
        fact_NN that_IN the_DT blood-brain_JJ barrier_NN is_VBZ incomplete_JJ [_NN 34_CD ]_NN ,_,
        provides_VBZ a_DT putative_JJ explanation_NN as_IN to_TO why_WRB neonates_NNS and_CC
        fetal_JJ mice_NNS 
        in_IN utero_NN appear_VBP to_TO be_VB more_RBR sensitive_JJ
        to_TO neurotoxins_NNS like_IN domoic_JJ acid_NN than_IN adult_NN animals_NNS [_NN 35_CD 36_CD
        37_CD ]_NN ._. Although_IN microglia_NN contribute_VB to_TO circa_NN 10_CD %_NN of_IN the_DT
        total_JJ glial_NN cell_NN population_NN in_IN the_DT central_JJ nervous_JJ system_NN
        (_( For_IN review_NN see_VB Ref_NNP ._. [_NN 38_CD ]_NN )_) ,_, to_TO our_PRP$ knowledge_NN ,_, no_DT
        previous_JJ studies_NNS have_VBP investigated_VBN the_DT potential_JJ role_NN of_IN
        microglia_NN in_IN mediating_VBG the_DT neurotoxic_JJ effects_NNS of_IN domoic_JJ
        acid_NN in_IN the_DT developing_VBG rat_NN brain_NN ._. We_PRP have_VBP recently_RB
        hypothesized_VBN that_IN the_DT marine_JJ toxin_NN domoic_JJ acid_NN might_MD affect_VB
        the_DT developing_VBG brain_NN by_IN directly_RB activating_VBG neonatal_NN rat_NN
        microglia_NN and_CC causing_VBG a_DT subsequent_JJ release_NN of_IN potentially_RB
        neurotoxic_JJ mediators_NNS [_NN 21_CD ]_NN ._.
        Prior_RB to_TO testing_VBG our_PRP$ hypothesis_NNS experimentally_RB ,_, and_CC
        determining_VBG whether_IN domoic_JJ acid_NN had_VBD the_DT potential_NN to_TO
        directly_RB activate_VBP rat_NN neonatal_NN microglia_NN 
        in_IN vitro_NN ,_, we_PRP thought_VBD that_IN it_PRP was_VBD of_IN
        critical_JJ importance_NN to_TO establish_VB that_IN :_: (_( 1_LS )_) the_DT domoic_JJ acid_NN
        preparation_NN used_VBN in_IN these_DT experiments_NNS was_VBD stable_JJ ,_, (_( 2_LS )_) rat_NN
        neonatal_NN microglia_NN isolated_VBN by_IN our_PRP$ methodology_NN expressed_VBD
        the_DT AMPA_NNP glutamate_NN receptor_NN GluR_NNP 4_CD subunit_NN which_WDT has_VBZ been_VBN
        observed_VBN in_IN activated_VBN rat_NN microglia_NN 
        in_IN vivo_NN [_NN 24_CD ]_NN and_CC ,_, (_( 3_LS )_) to_TO confirm_VB
        that_IN the_DT domoic_JJ acid_NN concentration_NN selected_VBN for_IN our_PRP$ 
        in_IN vitro_NN studies_NNS with_IN rat_NN neonatal_NN
        microglia_NN was_VBD one_CD that_WDT was_VBD clearly_RB toxic_JJ to_TO neuronal_NN cells_NNS 
        in_IN vitro_NN after_IN a_DT short-term_JJ
        exposure_NN ._.
        Although_IN it_PRP has_VBZ been_VBN reported_VBN that_IN the_DT solubility_NN of_IN
        domoic_JJ acid_NN in_IN water_NN is_VBZ approximately_RB 7_CD ._. 6_CD g_SYM /_NN L_NNP (_( 24_CD ._. 4_LS mM_NN )_) [_NN
        39_CD ]_NN ,_, rapid_JJ and_CC complete_JJ dissolution_NN of_IN domoic_JJ acid_NN was_VBD
        only_RB consistently_RB observed_VBD in_IN our_PRP$ laboratory_NN when_WRB preparing_VBG
        a_DT stock_NN domoic_JJ acid_NN solution_NN of_IN 12_CD ._. 5_LS mM_NN in_IN certified_VBN
        LPS-free_NNP water_NN ._. To_TO rule_VB out_RP the_DT possibility_NN that_IN domoic_JJ
        acid_NN might_MD have_VB degraded_JJ as_IN a_DT consequence_NN of_IN either_DT our_PRP$
        preparative_JJ method_NN or_CC the_DT subsequent_JJ freezing_NN (_( -_: 80_CD °_NN C_NNP )_) and_CC
        thawing_VBG of_IN the_DT domoic_JJ acid_NN stock_NN solution_NN ,_, electrospray_NN
        mass_NN spectrometry_NN was_VBD run_VBN on_IN both_DT the_DT domoic_JJ acid_NN stock_NN
        solution_NN (_( 12_CD ._. 5_LS mM_NN )_) and_CC the_DT dilutions_NNS prepared_VBN prior_RB to_TO the_DT
        experiments_NNS ._. Our_PRP$ electrospray_NN mass_NN spectrometry_NN results_NNS
        clearly_RB showed_VBD that_IN undegraded_JJ domoic_JJ acid_NN was_VBD present_JJ ,_,
        demonstrating_VBG the_DT stability_NN of_IN domoic_JJ acid_NN in_IN the_DT aqueous_JJ
        solutions_NNS that_WDT had_VBD been_VBN frozen_VBN at_IN -_: 80_CD °_NN C_NNP and_CC thawed_JJ prior_RB to_TO
        use_VB in_IN the_DT experiments_NNS ._. Interestingly_RB ,_, our_PRP$ observations_NNS
        complement_VB those_DT recently_RB reported_VBN on_IN domoic_JJ acid_NN 's_POS
        stability_NN in_IN saline_NN solutions_NNS [_NN 40_CD ]_NN ._.
        The_DT ionotropic_JJ AMPA_NNP glutamate_NN receptor_NN GluR_NNP 4_CD subunit_NN has_VBZ
        been_VBN shown_VBN to_TO be_VB expressed_VBN by_IN activated_VBN rat_NN adult_NN microglia_NN
        
        in_IN vivo_NN following_VBG transient_JJ forebrain_NN
        ischemia_NN [_NN 24_CD ]_NN and_CC also_RB 
        in_IN vitro_NN by_IN rat_NN neonatal_NN microglia_NN [_NN
        41_CD ]_NN ._. Because_IN it_PRP is_VBZ well_RB established_VBN that_IN AMPA_NNP glutamate_NN
        receptors_NNS bind_NN domoic_JJ acid_NN with_IN high_JJ affinity_NN in_IN the_DT
        nanomolar_NN range_NN [_NN 25_CD ]_NN ,_, we_PRP investigated_VBD the_DT presence_NN of_IN
        GluR_NNP 4_CD in_IN rat_NN neonatal_NN microglia_NN used_VBN in_IN our_PRP$ 
        in_IN vitro_NN experiments_NNS by_IN a_DT
        dual-labeling_JJ indirect_JJ immunofluorescence_NN technique_NN ._. Our_PRP$
        results_NNS clearly_RB confirmed_VBD that_IN GluR_NNP 4_CD was_VBD present_JJ in_IN the_DT rat_NN
        neonatal_NN microglia_NN used_VBN in_IN our_PRP$ 
        in_IN vitro_NN studies_NNS with_IN domoic_JJ acid_NN ,_,
        demonstrating_VBG that_IN the_DT protocol_NN used_VBN in_IN our_PRP$ laboratory_NN to_TO
        isolate_VB microglia_NN did_VBD not_RB appear_VB to_TO affect_VB the_DT presence_NN of_IN
        the_DT AMPA_NNP glutamate_NN receptor_NN GluR_NNP 4_CD subunits_NNS and_CC their_PRP$
        colocalization_NN with_IN the_DT CD_NNP 11_CD b_SYM /_NN c_SYM integrin_NN ._.
        The_DT cytotoxicity_NN of_IN domoic_JJ acid_NN to_TO neuronal_NN tissue_NN 
        in_IN vitro_NN has_VBZ been_VBN investigated_VBN over_IN a_DT
        wide_JJ range_NN of_IN concentrations_NNS ,_, namely_RB at_IN 10_CD μM_NN with_IN primary_JJ
        cultures_NNS of_IN cerebellar_NN neurons_NNS [_NN 30_CD 31_CD ]_NN as_RB well_RB as_IN
        hippocampal_NN slices_NNS [_NN 33_CD ]_NN ,_, at_IN 100_CD μM_NN with_IN cultured_JJ
        prenatal_NN rat_NN hippocampal_NN neurons_NNS [_NN 29_CD ]_NN and_CC at_IN 20_CD mM_NN with_IN
        rat_NN lumbar_NN spinal_JJ interneurons_NNS [_NN 28_CD ]_NN ._. In_IN order_NN to_TO
        determine_VB a_DT concentration_NN of_IN domoic_JJ acid_NN for_IN our_PRP$ 
        in_IN vitro_NN studies_NNS that_WDT was_VBD toxic_JJ to_TO
        cerebellar_NN granule_NN cells_NNS after_IN a_DT short-term_JJ exposure_NN in_IN our_PRP$
        experimental_JJ conditions_NNS ,_, we_PRP completed_VBD a_DT viability_NN study_NN
        using_VBG the_DT WST-_NNP 1_CD method_NN ._. The_DT results_NNS of_IN this_DT study_NN
        demonstrated_VBN that_IN even_RB though_IN the_DT highest_JJS concentration_NN of_IN
        domoic_JJ acid_NN tested_VBD ,_, namely_RB 1_CD mM_NN ,_, did_VBD 
        not_RB affect_VB rat_NN neonatal_NN microglia_NN
        viability_NN 
        in_IN vitro_NN ,_, domoic_JJ acid_NN concentrations_NNS
        as_RB low_JJ as_IN 10_CD μM_NN were_VBD clearly_RB cytotoxic_JJ to_TO cerebellar_NN
        granule_NN neurons_NNS after_IN a_DT 6_CD hour_NN exposure_NN ._. Because_IN cerebellar_NN
        granule_NN cells_NNS appear_VBP to_TO be_VB inherently_RB resistant_JJ to_TO the_DT
        cytotoxic_JJ effects_NNS of_IN excitatory_NN amino_JJ acids_NNS and_CC
        neurotoxicity_NN appears_VBZ to_TO be_VB "_'' 
        ._. ._. ._. facilitated_JJ when_WRB cellular_JJ energy_NN is_VBZ
        limited_VBN in_IN cultured_JJ cerebellar_NN neurons_NNS ._. ._. ._. "_'' [_NN 42_CD ]_NN ,_,
        perhaps_RB manipulating_VBG the_DT experimental_JJ conditions_NNS (_( e_SYM ._. g_SYM ._.
        lowering_VBG the_DT temperature_NN to_TO 22_CD °_NN C_NNP )_) might_MD have_VB enhanced_VBN the_DT
        intensity_NN of_IN the_DT observed_VBN cytotoxicity_NN to_TO cerebellar_NN
        neurons_NNS even_RB further_RBR ,_, as_IN was_VBD reported_VBN recently_RB when_WRB
        cerebellar_NN granule_NN cells_NNS were_VBD exposed_VBN to_TO 10_CD μM_NN domoic_JJ acid_NN
        for_IN up_IN to_TO 24_CD hours_NNS [_NN 43_CD ]_NN ._. Future_NNP work_NN is_VBZ necessary_JJ to_TO
        determine_VB if_IN similar_JJ changes_NNS in_IN the_DT experimental_JJ conditions_NNS
        might_MD also_RB increase_VB the_DT toxicity_NN of_IN domoic_JJ acid_NN to_TO rat_VB
        neonatal_NN microglia_NN 
        in_IN vitro_NN ._. It_PRP is_VBZ interesting_JJ to_TO note_VB ,_,
        however_RB ,_, that_IN in_IN newborn_JJ mice_NNS a_DT brief_JJ local_JJ application_NN of_IN
        2_CD mM_NN domoic_JJ acid_NN to_TO the_DT exposed_VBN cortical_JJ surface_NN led_VBN to_TO a_DT
        massive_JJ degeneration_NN of_IN AMPA_NNP /_NN KA_NNP GluR_NNP receptor_NN positive_JJ
        Cajal-_NNP Retzius_NNP neurons_NNS [_NN 44_CD ]_NN ,_, severe_JJ impairment_NN of_IN
        cortical_JJ neuronal_NN migration_NN 
        in_IN vivo_NN and_CC malformation_NN of_IN the_DT
        domoic_JJ acid-treated_JJ neocortex_NN [_NN 44_CD ]_NN ._. Thus_RB ,_, because_IN 1_CD mM_NN
        domoic_JJ acid_NN was_VBD clearly_RB toxic_JJ to_TO cerebellar_NN granule_NN neurons_NNS
        both_DT 
        in_IN vitro_NN (_( our_PRP$ current_JJ study_NN )_) and_CC 
        in_IN vivo_NN [_NN 44_CD ]_NN ,_, we_PRP selected_VBD 1_CD mM_NN
        domoic_JJ acid_NN for_IN the_DT experiments_NNS with_IN rat_NN neonatal_NN microglia_NN
        reported_VBD herein_NN ._.
        Having_VBG determined_VBN that_IN our_PRP$ domoic_JJ acid_NN preparation_NN was_VBD
        stable_JJ and_CC undegraded_JJ ,_, that_DT rat_NN neonatal_NN microglia_NN
        expressed_VBD GluR_NNP 4_CD 
        in_IN vitro_NN and_CC that_IN 1_CD mM_NN domoic_JJ acid_NN
        was_VBD toxic_JJ to_TO cerebellar_NN granule_NN neurons_NNS 
        in_IN vitro_NN but_CC did_VBD not_RB affect_VB the_DT
        viability_NN of_IN rat_NN neonatal_NN microglia_NN ,_, we_PRP then_RB investigated_VBD
        whether_IN a_DT short_JJ term_NN 1_CD -_: 6_CD hour_NN exposure_NN to_TO 1_CD mM_NN domoic_JJ acid_NN
        would_MD activate_VBP rat_VB neonatal_NN microglia_NN 
        in_IN vitro_NN ._. In_IN all_DT our_PRP$ experiments_NNS we_PRP
        compared_VBD domoic_JJ acid_NN 's_POS effect_NN with_IN that_DT of_IN 10_CD ng_NN /_NN ml_NN LPS_NNP ,_, a_DT
        potent_JJ and_CC rapid_JJ microglia_NN activator_NN [_NN 7_CD ]_NN ,_, to_TO clearly_RB
        show_VB that_DT rat_NN neonatal_NN microglia_NN were_VBD able_JJ to_TO become_VB
        rapidly_RB activated_VBN and_CC release_NN mediators_NNS ,_, i_NNP ._. e_SYM ._. TNF-α_NNP ,_, MMP-_NNP 9_CD
        and_CC O_NNP 
        2_CD -_: upon_IN short-term_JJ 
        in_IN vitro_NN treatment_NN ._. We_PRP have_VBP recently_RB
        reported_VBN on_IN the_DT kinetics_NNS of_IN LPS_NNP activation_NN of_IN rat_NN neonatal_NN
        microglia_NN and_CC the_DT concomitant_NN release_NN of_IN TNF-α_NNP protein_NN ,_,
        MMP-_NNP 9_CD and_CC O_NNP 
        2_CD -_: [_NN 7_CD ]_NN ._. These_DT three_CD microglia_NN
        mediators_NNS are_VBP currently_RB thought_VBN to_TO participate_VB in_IN neuronal_NN
        and_CC glial_NN injury_NN 
        in_IN vivo_NN [_NN 10_CD 45_CD ]_NN ._.
        TNF-α_NNP is_VBZ a_DT cytokine_NN that_WDT can_MD mediate_VB myelin_NN and_CC
        oligodendrocyte_NN damage_NN in_IN vitro_NN [_NN 10_CD ]_NN and_CC thought_VBD to_TO play_VB
        a_DT key_JJ role_NN in_IN central_JJ nervous_JJ system_NN pathologies_NNS [_NN 3_CD ]_NN ._. 
        In_IN vitro_NN E_NNP ._. coli_NNS LPS_NNP can_MD trigger_VB rat_NN
        neonatal_NN microglia_NN to_TO rapidly_RB activate_VBP TNF-α_NNP gene_NN
        expression_NN and_CC subsequent_JJ protein_NN release_NN [_NN 46_CD ]_NN in_IN a_DT
        concentration-_NN and_CC time-dependent_JJ manner_NN ._. Although_IN 
        in_IN vitro_NN exposure_NN of_IN rat_NN neonatal_NN
        microglia_NN to_TO 10_CD ng_NN /_NN ml_NN LPS_NNP resulted_VBD ,_, as_IN expected_VBN ,_, in_IN a_DT rapid_JJ
        elevation_NN of_IN both_DT TNF-α_NNP gene_NN expression_NN and_CC protein_NN
        release_NN ,_, we_PRP observed_VBD only_RB a_DT small_JJ effect_NN of_IN 1_CD mM_NN domoic_JJ
        acid_NN on_IN TNF-α_NNP gene_NN expression_NN ._. Interestingly_RB ,_, the_DT slight_JJ
        rise_NN in_IN TNF-α_NNP expression_NN yielded_VBD a_DT 53_CD %_NN (_( p_NN <_NN 0_CD ._. 01_CD )_)
        increase_NN of_IN TNF-α_NNP protein_NN release_NN 4_CD hours_NNS after_IN stimulation_NN
        with_IN 1_CD mM_NN domoic_JJ acid_NN ._. Although_IN we_PRP feel_VBP it_PRP may_MD be_VB premature_JJ
        to_TO speculate_VB on_IN the_DT putative_JJ pathophysiological_JJ
        significance_NN of_IN this_DT increase_NN in_IN immunoreactive_JJ TNF-α_NNP ,_, the_DT
        fact_NN that_IN TNF-α_NNP can_MD induce_VB MMP-_NNP 9_CD expression_NN in_IN macrophages_NNS
        [_NN 47_CD ]_NN ,_, suggests_VBZ that_IN TNF-α_NNP may_MD play_VB an_DT as_RB yet_RB
        undetermined_JJ role_NN in_IN the_DT mechanism_NN of_IN MMP-_NNP 9_CD release_NN
        observed_VBD in_IN our_PRP$ studies_NNS ._. Futhermore_NNP immuno-_NN PCR_NNP techniques_NNS ,_,
        which_WDT have_VBP allowed_VBN investigators_NNS to_TO study_VB the_DT kinetics_NNS of_IN
        TNF-α_NNP release_NN at_IN the_DT femtomolar_NN range_NN [_NN 48_CD ]_NN ,_, might_MD help_VB
        to_TO study_VB the_DT kinetics_NNS of_IN picomolar_NN microglia_NN TNF-α_NNP release_NN
        triggered_VBN by_IN a_DT short-term_JJ exposure_NN to_TO domoic_JJ acid_NN ._. These_DT
        proposed_VBN studies_NNS might_MD be_VB of_IN considerable_JJ significance_NN in_IN
        view_NN of_IN the_DT fact_NN that_IN similar_JJ amounts_NNS of_IN TNF-α_NNP release_NN have_VBP
        
        also_RB been_VBN observed_VBN after_IN a_DT 2_CD hour_NN
        stimulation_NN of_IN rat_NN neonatal_NN microglia_NN with_IN kainic_JJ acid_NN ,_, a_DT
        domoic_JJ acid_NN and_CC glutamate_NN analog_NN [_NN 41_CD ]_NN ._. Taken_VBN together_RB ,_,
        our_PRP$ results_NNS with_IN domoic_JJ acid_NN as_RB well_RB as_IN those_DT of_IN Noda_NNP et_CC
        al_NN ._. [_NN 41_CD ]_NN with_IN kainic_JJ acid_NN support_NN the_DT recently_RB proposed_VBN
        notion_NN that_IN TNF-α_NNP might_MD not_RB be_VB neurotoxic_JJ in_IN some_DT
        situations_NNS when_WRB the_DT release_NN of_IN this_DT mediator_NN is_VBZ low_JJ ,_, and_CC
        therefore_RB might_MD not_RB be_VB a_DT necessary_JJ requirement_NN for_IN neuronal_NN
        death_NN involving_VBG excitatory_NN amino_JJ acids_NNS [_NN 49_CD ]_NN ._.
        Proteases_NNP such_JJ as_IN MMP-_NNP 9_CD [_NN 9_CD ]_NN ,_, which_WDT have_VBP been_VBN
        implicated_VBN in_IN sublethal_NN and_CC lethal_JJ neuronal_NN and_CC glial_NN
        injury_NN 
        in_IN vivo_NN in_IN "_'' 
        ._. ._. ._. central_JJ nervous_JJ system_NN
        diseases_NNS ._. ._. ._. "_'' [_NN 50_CD ]_NN are_VBP released_VBN by_IN LPS-activated_NNP rat_NN
        neonatal_NN microglia_NN 
        in_IN vitro_NN [_NN 7_CD ]_NN ,_, by_IN a_DT mechanism_NN that_WDT
        may_MD involve_VB TNF-α_NNP [_NN 47_CD 51_CD ]_NN ._. Clearly_RB because_IN in_IN our_PRP$
        studies_NNS 1_CD mM_NN domoic_JJ acid_NN stimulated_VBN both_DT an_DT increase_NN in_IN
        TNF-α_NNP release_NN ,_, as_RB well_RB as_IN MMP-_NNP 9_CD ,_, further_JJ investigation_NN of_IN a_DT
        possible_JJ relationship_NN between_IN these_DT two_CD events_NNS may_MD be_VB
        important_JJ ._. Furthermore_RB ,_, though_IN the_DT magnitude_NN of_IN MMP-_NNP 9_CD
        secretion_NN stimulated_VBN by_IN domoic_JJ acid_NN was_VBD lower_JJR than_IN the_DT one_CD
        observed_VBD with_IN LPS_NNP ,_, this_DT is_VBZ the_DT first_JJ observation_NN to_TO our_PRP$
        knowledge_NN that_IN an_DT excitatory_NN amino_JJ acid_NN like_IN domoic_JJ acid_NN is_VBZ
        able_JJ to_TO trigger_VB MMP-_NNP 9_CD release_NN 
        in_IN vitro_NN ._. Although_IN at_IN the_DT present_JJ
        time_NN it_PRP is_VBZ difficult_JJ to_TO comment_VB on_IN the_DT pathophysiological_JJ
        significance_NN of_IN increased_VBN MMP-_NNP 9_CD release_NN ,_, it_PRP is_VBZ perhaps_RB
        noteworthy_JJ that_WDT increased_VBD MMP-_NNP 9_CD expression_NN has_VBZ been_VBN
        correlated_JJ with_IN increased_VBN apoptosis_NNS [_NN 52_CD ]_NN and_CC increased_VBN
        microvascular_NN permeability_NN [_NN 53_CD ]_NN ,_, events_NNS possibly_RB
        involved_VBN in_IN the_DT opening_NN of_IN the_DT blood-brain_JJ barrier_NN [_NN 54_CD ]_NN
        and_CC potential_JJ injury_NN to_TO the_DT brain_NN [_NN 50_CD ]_NN ._.
        Microglia_NNP constitute_VBP the_DT main_JJ leukocyte-dependent_JJ source_NN
        of_IN reactive_JJ oxygen_NN species_NNS in_IN the_DT central_JJ nervous_JJ system_NN [_NN
        55_CD ]_NN ._. Since_IN microglia_NN were_VBD first_RB shown_VBN to_TO release_VB O_NNP 
        2_CD -_: [_NN 6_CD ]_NN numerous_JJ investigations_NNS have_VBP
        been_VBN undertaken_VBN over_IN the_DT past_JJ 14_CD years_NNS to_TO characterize_VB
        agents_NNS than_IN can_MD either_DT prime_JJ and_CC /_NN or_CC trigger_VB the_DT microglia_NN O_NNP
        
        2_LS -_: generating_NN system_NN (_( for_IN review_NN see_VB
        Ref_NNP ._. [_NN 3_CD ]_NN )_) ._. In_IN our_PRP$ current_JJ experiments_NNS ,_, we_PRP observed_VBD that_IN
        1_CD mM_NN domoic_JJ acid_NN did_VBD not_RB prime_JJ rat_NN neonatal_NN microglia_NN for_IN
        PMA-stimulated_NNP O_NNP 
        2_CD -_: release_NN ,_, again_RB in_IN marked_JJ contrast_NN
        with_IN LPS_NNP ._. Interestingly_RB though_RB ,_, domoic_JJ acid_NN appeared_VBD to_TO
        modulate_VBP LPS-primed_NNP rat_NN neonatal_NN microglia_NN O_NNP 
        2_CD -_: release_NN ,_, suggesting_VBG that_IN domoic_JJ acid_NN
        might_MD potentially_RB play_VB a_DT role_NN in_IN the_DT 
        in_IN vivo_NN modulation_NN of_IN activated_VBN rat_NN
        neonatal_NN microglia_NN ,_, and_CC perhaps_RB other_JJ leukocytes_NNS capable_JJ of_IN
        releasing_VBG O_NNP 
        2_CD -_: ._.
        In_IN summary_NN ,_, in_IN our_PRP$ experiments_NNS the_DT 
        in_IN vitro_NN effect_NN of_IN a_DT 1_CD -_: 6_CD hour_NN
        exposure_NN to_TO domoic_JJ acid_NN on_IN rat_NN neonatal_NN microglia_NN
        activation_NN and_CC concomitant_NN TNF-α_NNP ,_, MMP-_NNP 9_CD and_CC O_NNP 
        2_CD -_: release_NN was_VBD clearly_RB 
        distinct_JJ in_IN its_PRP$ magnitude_NN from_IN that_DT
        observed_VBD after_IN exposure_NN to_TO LPS_NNP ,_, an_DT agent_NN involved_VBN in_IN
        endotoxic_JJ shock_NN and_CC other_JJ central_JJ nervous_JJ pathologies_NNS [_NN 3_CD ]_NN
        ._. Even_RB though_IN this_DT present_JJ study_NN was_VBD limited_VBN to_TO the_DT study_NN
        of_IN the_DT 
        in_IN vitro_NN effects_NNS of_IN domoic_JJ acid_NN on_IN
        three_CD microglia_NN mediators_NNS ,_, namely_RB TNF-α_NNP ,_, MMP-_NNP 9_CD and_CC O_NNP 
        2_CD -_: ,_, it_PRP provides_VBZ the_DT first_JJ experimental_JJ
        evidence_NN to_TO our_PRP$ knowledge_NN that_IN domoic_JJ acid_NN ,_, at_IN 
        in_IN vitro_NN concentrations_NNS that_WDT are_VBP
        toxic_JJ to_TO neuronal_NN cells_NNS ,_, can_MD trigger_VB a_DT limited_JJ activation_NN
        of_IN rat_NN neonatal_NN microglia_NN and_CC the_DT concomitant_NN release_NN of_IN
        modest_JJ though_IN statistically_RB significant_JJ amounts_NNS of_IN TNF-α_NNP
        and_CC MMP-_NNP 9_CD ._.
        Our_PRP$ investigation_NN does_VBZ not_RB exclude_VB the_DT possibility_NN that_IN 
        in_IN vitro_NN domoic_JJ acid_NN may_MD affect_VB
        expression_NN of_IN genes_NNS and_CC mediators_NNS that_WDT might_MD support_VB
        survival_NN of_IN neuronal_NN cells_NNS ._. Several_JJ lines_NNS of_IN evidence_NN
        appear_VBP to_TO support_VB this_DT possibility_NN ._. Thus_RB ,_, in_IN a_DT recent_JJ
        report_NN ionotropic_JJ AMPA_NNP glutamate_NN receptors_NNS were_VBD shown_VBN to_TO "_'' 
        ._. ._. ._. function_NN not_RB only_RB as_IN ion_NN channels_NNS but_CC
        also_RB as_IN cell-surface_JJ transducers_NNS by_IN means_NNS of_IN their_PRP$
        interaction_NN with_IN the_DT Src-family_NNP non-receptor_JJ protein_NN kinase_NN
        Lyn_NNP ._. ._. ._. "_'' ,_, ultimately_RB leading_VBG to_TO "_'' 
        ._. ._. ._. expression_NN of_IN brain-derived_JJ
        neurotrophic_JJ factor_NN (_( BDNF_NNP )_) messenger_NN RNA_NNP "_'' in_IN
        cerebellar_NN primary_JJ culture_NN neurons_NNS [_NN 56_CD ]_NN ._. In_IN another_DT
        study_NN ,_, basic_JJ fibroblast_NN growth_NN factor_NN (_( bFGF_NN )_) was_VBD shown_VBN to_TO
        significantly_RB protect_VB cerebellar_NN granule_NN neurons_NNS in_IN culture_NN
        from_IN the_DT neurotoxicity_NN by_IN domoic_JJ acid_NN ,_, perhaps_RB "_'' 
        ._. ._. ._. through_IN a_DT direct_JJ interaction_NN of_IN bFGF_NN
        and_CC bFGF_NN receptors_NNS on_IN the_DT neuronal_NN surface_NN ._. ._. ._. "_'' [_NN 32_CD ]_NN
        ._. Interestingly_RB ,_, because_IN rat_NN neonatal_NN microglia_NN have_VBP been_VBN
        shown_VBN to_TO express_VB BDNF_NNP [_NN 57_CD ]_NN and_CC bFGF_NN [_NN 58_CD ]_NN ,_, and_CC in_IN view_NN
        of_IN the_DT fact_NN that_IN LPS_NNP can_MD affect_VB BDNF_NNP gene_NN expression_NN in_IN rat_NN
        neonatal_NN microglia_NN cells_NNS [_NN 59_CD ]_NN ,_, experiments_NNS are_VBP currently_RB
        underway_NN in_IN our_PRP$ laboratory_NN to_TO determine_VB if_IN domoic_JJ acid_NN may_MD
        affect_VB neonatal_NN rat_NN microglia_NN expression_NN of_IN both_DT BDNF_NNP and_CC
        bFGF_NN ._. However_RB ,_, we_PRP do_VBP not_RB rule_VB out_RP the_DT possibility_NN that_IN
        growth_NN factors_NNS other_JJ than_IN BDNF_NNP and_CC bFGF_NN could_MD be_VB released_VBN
        by_IN domoic_JJ acid-stimulated_JJ neonatal_NN microglia_NN cells_NNS and_CC play_VB
        a_DT role_NN in_IN neuroprotection_NN from_IN excitotoxic_JJ injury_NN ._.
      
      
        Conclusions_NNP
        Our_PRP$ present_JJ results_NNS provide_VBP the_DT first_JJ experimental_JJ
        evidence_NN to_TO support_VB the_DT hypothesis_NNS that_IN a_DT 
        direct_JJ interaction_NN of_IN domoic_JJ acid_NN
        with_IN rat_NN neonatal_NN microglia_NN 
        in_IN vitro_NN ,_, leads_VBZ to_TO the_DT release_NN of_IN
        small_JJ but_CC statistically_RB significant_JJ amounts_NNS of_IN two_CD
        potentially_RB neurotoxic_JJ mediators_NNS ,_, namely_RB TNF-α_NNP and_CC MMP-_NNP 9_CD
        after_IN a_DT short-term_JJ 
        in_IN vitro_NN exposure_NN ._. These_DT observations_NNS
        are_VBP of_IN considerable_JJ significance_NN if_IN future_JJ research_NN
        demonstrates_VBZ that_IN higher_JJR levels_NNS of_IN TNF-α_NNP and_CC MMP-_NNP 9_CD are_VBP
        generated_VBN by_IN neonatal_NN rat_NN microglia_NN as_IN a_DT result_NN of_IN either_DT
        (_( 1_LS )_) a_DT synergistic_JJ interaction_NN between_IN domoic_JJ acid_NN "_'' 
        ._. ._. ._. when_WRB in_IN association_NN with_IN subtoxic_JJ
        concentrations_NNS of_IN excitatory_NN amino_JJ acids_NNS ._. ._. ._. "_'' a_DT
        combination_NN that_WDT has_VBZ been_VBN shown_VBN to_TO increase_VB the_DT
        neurotoxicity_NN of_IN domoic_JJ acid_NN to_TO primary_JJ cultures_NNS of_IN
        cerebellar_NN neurons_NNS [_NN 31_CD ]_NN or_CC (_( 2_LS )_) an_DT increase_NN in_IN the_DT time_NN of_IN
        exposure_NN to_TO domoic_JJ acid_NN ,_, as_IN we_PRP have_VBP reported_VBN is_VBZ the_DT case_NN
        with_IN LPS_NNP [_NN 7_CD ]_NN ._. The_DT fact_NN that_IN domoic_JJ acid_NN has_VBZ been_VBN shown_VBN
        to_TO activate_VBP rat_NN microglia_NN several_JJ days_NNS after_IN 
        in_IN vivo_NN administration_NN [_NN 60_CD ]_NN clearly_RB
        raises_VBZ this_DT latter_JJ possibility_NN ._.
        An_DT understanding_NN of_IN the_DT potential_JJ neurotoxic_JJ and_CC /_NN or_CC
        neuroprotective_JJ effects_NNS of_IN domoic_JJ acid_NN in_IN neonatal_NN rats_NNS
        will_MD ultimately_RB lead_VB to_TO a_DT better_JJR understanding_NN of_IN domoic_JJ
        acid_NN 's_POS effect_NN in_IN neonatal_NN human_JJ development_NN ._. This_DT concept_NN
        is_VBZ supported_VBN by_IN the_DT established_VBN fact_NN that_IN glutamate_NN
        receptors_NNS are_VBP highly_RB conserved_JJ between_IN mammals_NNS [_NN 26_CD ]_NN ._.
        Ultimately_RB studies_VBZ contributing_VBG to_TO the_DT characterization_NN of_IN
        the_DT early_JJ biochemical_JJ as_IN well_RB as_IN cellular_JJ events_NNS subsequent_JJ
        to_TO an_DT intoxication_NN with_IN the_DT marine_JJ toxin_NN domoic_JJ acid_NN will_MD
        yield_VB new_JJ insights_NNS for_IN the_DT rationale_NN development_NN of_IN novel_NN
        therapeutic_JJ interventions_NNS for_IN the_DT prevention_NN and_CC treatment_NN
        of_IN amnesic_JJ shellfish_NN poisoning_NN ._.
      
      
        Materials_NNS and_CC Methods_NNP
        
          Reagents_NNP
          LPS_NNP B_NNP (_( Escherichia_NNP coli_NNS 026_CD :_: B_NNP 6_CD )_) was_VBD obtained_VBN from_IN
          Difco_NNP Laboratories_NNPS (_( Detroit_NNP ,_, MI_NNP )_) ;_: crystalline_JJ lyophilized_JJ
          domoic_JJ acid_NN was_VBD purchased_VBN from_IN Diagnostics_NNPS Chemicals_NNPS Ltd_NNP ._.
          (_( Oxford_NNP ,_, CT_NNP )_) and_CC was_VBD dissolved_VBN in_IN LPS-free_NNP water_NN obtained_VBN
          from_IN GIBCO-BRL_NNP (_( Grand_NNP Island_NNP ,_, NY_NNP )_) to_TO prepare_VB a_DT 12_CD ._. 5_LS mM_NN
          stock_NN [_NN 39_CD ]_NN and_CC stored_VBD at_IN -_: 80_CD °_NN C_NNP ;_: goat_NN anti-mouse_JJ IgG_NNP
          conjugated_JJ with_IN tetramethylrhodamine_NN isothiocyanate_NN
          (_( TRITC_NNP )_) and_CC goat_NN anti-rabbit_JJ IgG_NNP conjugated_JJ with_IN
          fluorescein_NN isothiocyanate_NN (_( FITC_NNP )_) were_VBD obtained_VBN from_IN
          Sigma_NNP Chemical_NNP Co_NNP ._. (_( St_NNP ._. Louis_NNP ,_, MO_NNP )_) ._. PMA_NNP was_VBD maintained_VBN at_IN
          -_: 80_CD °_NN C_NNP as_IN a_DT 10_CD mM_NN stock_NN solution_NN in_IN DMSO_NNP ._. Dulbecco_NNP 's_POS
          modified_VBN Eagle_NNP medium_NN (_( DMEM_NNP )_) with_IN high_JJ glucose_NN (_( 4_CD ,_, 500_CD
          mg_NN /_NN l_NN )_) ,_, Neurobasal-_NNP A_DT medium_NN ,_, serum-free_JJ B-_NNP 27_CD supplement_NN ._.
          Hank_NNP 's_POS balanced_JJ salt_NN solution_NN (_( HBSS_NNP )_) ,_, penicillin_NN (_( P_NN )_) ,_,
          streptomycin_NN (_( S_NNP )_) ,_, trypsin_NN (_( 0_CD ._. 25_CD %_NN )_) -_: EDTA_NNP (_( 1_CD mM_NN )_) and_CC trypan_NN
          blue_NN were_VBD purchased_VBN from_IN GIBCO-BRL_NNP (_( Grand_NNP Island_NNP ,_, NY_NNP )_) ;_:
          certified_VBN heat-inactivated_JJ fetal_JJ bovine_JJ serum_NN (_( FBS_NNP )_) was_VBD
          obtained_VBN from_IN Hyclone_NNP (_( Logan_NNP ,_, UT_NNP )_) ;_: mouse_NN anti-rat_JJ CD_NNP 11_CD b_SYM /_NN c_SYM
          monoclonal_NN antibody_NN (_( OX-_NNP 42_CD )_) and_CC rabbit_NN anti-glutamate_JJ
          receptor_NN (_( GluR_NNP 4_LS )_) polyclonal_NN antibody_NN were_VBD purchased_VBN from_IN
          Pharmingen_NNP (_( San_NNP Diego_NNP ,_, CA_NNP )_) ._. A_DT LPS_NNP stock_NN of_IN 1_CD mg_NN /_NN ml_NN was_VBD
          prepared_VBN in_IN a_DT 0_CD ._. 9_CD %_NN sodium_NN chloride_NN nonpyrogenic_JJ solution_NN
          from_IN Baxter_NNP Healthcare_NNP Corp_NNP ._. (_( Toronto_NNP ,_, ONT_NNP ,_, Canada_NNP )_) and_CC
          then_RB diluted_VBN with_IN DMEM_NNP plus_CC 10_CD %_NN FBS_NNP plus_CC P_NN and_CC S_NNP to_TO the_DT
          appropriate_JJ concentration_NN used_VBN in_IN our_PRP$ experiments_NNS ._. Both_DT
          the_DT LPS_NNP stock_NN solution_NN [_NN 10_CD ng_NN /_NN ml_NN ]_NN and_CC dilutions_NNS were_VBD
          stored_VBN at_IN -_: 80_CD °_NN C_NNP ,_, thawed_JJ prior_RB to_TO each_DT experiment_NN and_CC
          discarded_VBN after_IN use_NN ._.
        
        
          LPS_NNP containment_NN
          To_TO inactivate_NN extraneous_JJ LPS_NNP ,_, all_DT glassware_NN and_CC metal_NN
          spatulas_NNS were_VBD baked_JJ for_IN 4_CD hours_NNS at_IN 180_CD °_NN C_NNP ._. Sterile_NNP and_CC
          LPS-free_NNP 75_CD -_: and_CC 162_CD -_: cm_NN 2_CD vented_VBD cell_NN culture_NN flasks_NNS ,_,
          24_CD -_: well_RB flat-bottom_JJ culture_NN clusters_NNS ,_, 96_CD -_: well_RB cell_NN
          culture_NN clusters_NNS and_CC disposable_JJ serological_JJ pipettes_NNS were_VBD
          purchased_VBN from_IN Costar_NNP Corporation_NNP (_( Cambridge_NNP ,_, MA_NNP )_) ,_, while_IN
          polystyrene_NN cell_NN culture_NN dishes_NNS (_( 60_CD ×_NN 15_CD mm_NN )_) were_VBD
          obtained_VBN from_IN Corning_NNP Glass_NNP Works_NNP (_( Corning_NNP ,_, NY_NNP )_) ._. Sterile_NNP
          and_CC pyrogen-free_JJ Eppendorf_NNP Biopur_NNP pipette_NN tips_NNS were_VBD
          purchased_VBN from_IN Brinkmann_NNP Instruments_NNP ,_, Inc_NNP ._. (_( Westbury_NNP ,_,
          NY_NNP )_) ._.
        
        
          Electrospray_NNP mass_NN spectrometry_NN of_IN domoic_JJ
          acid_NN
          The_DT presence_NN of_IN undegraded_JJ domoic_JJ acid_NN in_IN the_DT stock_NN
          solution_NN (_( 12_CD ._. 5_LS mM_NN )_) and_CC dilutions_NNS prepared_VBN with_IN LPS-free_NNP
          water_NN was_VBD confirmed_VBN by_IN electrospray_NN mass_NN spectrometry_NN
          prior_RB to_TO the_DT experiments_NNS ._. Electrospray_NNP mass_NN spectrometry_NN
          was_VBD performed_VBN in_IN the_DT Mass_NNP Spectrometry_NNP Laboratory_NNP ,_, School_NNP
          of_IN Chemical_NNP Sciences_NNPS ,_, University_NNP of_IN Illinois_NNP ._. All_DT
          electrospray_NN mass_NN spectrometry_NN spectra_NN were_VBD acquired_VBN on_IN a_DT
          Micromass_NNP Quattro_NNP triple_JJ quadruple_NN mass_NN spectrometer_NN
          (_( Manchester_NNP ,_, UK_NNP )_) employing_VBG a_DT Megaflow_NNP probe_NN and_CC ion_NN
          source_NN ._. The_DT data_NNS were_VBD acquired_VBN in_IN the_DT continuum_NN mode_NN ._. All_DT
          solvents_NNS were_VBD Fisher_NNP Optima_NNP or_CC Burdick_NNP and_CC Jackson_NNP
          Distilled-in-_NNP Glass_NNP grade_NN ._. Deionized_NNP water_NN was_VBD obtained_VBN
          from_IN a_DT Barstead_NNP NANOpure_NNP system_NN ._. Domoic_NNP acid_NN samples_NNS (_( 10_CD
          μl_NN )_) were_VBD diluted_VBN with_IN 40_CD μl_NN of_IN 50_CD /_NN 50_CD H_NNP 
          2_CD O_NNP /_NN AcN_NNP with_IN 0_CD ._. 1_CD %_NN formic_JJ acid_NN as_IN the_DT
          mobile_JJ flow_NN phase_NN ._. An_DT aliquot_NN (_( 10_CD μl_NN )_) was_VBD injected_VBN using_VBG
          a_DT model_NN 7125_CD Rheodyne_NNP valve_NN with_IN a_DT 10_CD μl_NN loop_NN ._. The_DT sample_NN
          was_VBD nebulized_JJ with_IN dry_JJ nitrogen_NN at_IN a_DT flow_NN of_IN 15_CD l_NN /_NN hr_NN and_CC
          the_DT nitrogen_NN bath_NN gas_NN flow_NN as_IN 300_CD l_NN /_NN h_NN ._. The_DT electrospray_NN
          mass_NN spectrometry_NN source_NN was_VBD typically_RB operated_VBN with_IN 3_CD ._. 5_CD
          kV_NN on_IN the_DT electrospray_NN mass_NN spectrometry_NN probe_NN and_CC 400_CD
          volts_NNS on_IN the_DT counter_JJ electrode_NN at_IN a_DT temperature_NN of_IN 65_CD °_NN C_NNP ._.
          The_DT cone_NN voltage_NN was_VBD 25_CD volts_NNS ._. Normal_NNP electrospray_NN mass_NN
          spectrometry_NN spectra_NN were_VBD acquired_VBN employing_VBG MS_NNP 1_CD over_IN
          the_DT desired_VBN mass_NN range_NN in_IN 10_CD -_: 
          s_VBZ at_IN unit_NN resolution_NN (_( 50_CD %_NN valley_NN )_) ._.
          The_DT mass_NN scale_NN of_IN the_DT instrument_NN was_VBD calibrated_VBN employing_VBG
          CsI_NNP (_( 4_CD mg_NN /_NN ml_NN in_IN 50_CD /_NN 50_CD H_NNP 
          2_CD O_NNP /_NN AcN_NNP )_) ._.
        
        
          Immunofluorescent_NNP labeling_VBG of_IN GluR_NNP 4_CD and_CC CD_NNP 11_CD b_SYM /_NN c_SYM on_IN
          rat_NN neonatal_NN microglia_NN
          The_DT α-amino-_JJ 3_CD -_: hydroxy-_NN 5_CD -_: methyl-_NN 4_CD -_: isoxazole_NN propionic_JJ
          acid_NN (_( AMPA_NNP )_) glutamate-_NN 4_CD receptor_NN subunit_NN (_( GluR_NNP 4_LS )_) and_CC the_DT
          integrin_NN CD_NNP 11_CD b_SYM /_NN c_SYM were_VBD visualized_JJ by_IN indirect_JJ
          immunofluorescence_NN using_VBG a_DT dual_JJ labeling_VBG procedure_NN ._. Rat_NNP
          neonatal_NN microglia_NN on_IN glass_NN coverslips_NNS were_VBD fixed_VBN and_CC
          permeabilized_JJ in_IN -_: 20_CD °_NN C_NNP methanol_NN for_IN 10_CD min_NN ,_, and_CC then_RB
          blocked_VBN with_IN 10_CD %_NN goat_NN serum_NN in_IN phosphate_NN buffered_JJ saline_NN
          (_( PBS_NNP )_) at_IN 25_CD °_NN C_NNP for_IN 5_CD min_NN ._. The_DT samples_NNS were_VBD incubated_JJ for_IN
          45_CD min_NN at_IN 37_CD °_NN C_NNP in_IN PBS_NNP containing_VBG the_DT primary_JJ antibodies_NNS ,_,
          a_DT rabbit_NN anti-rat_JJ GluR_NNP 4_CD at_IN a_DT 1_CD :_: 50_CD dilution_NN ,_, and_CC a_DT mouse_NN
          anti-rat_JJ CD_NNP 11_CD b_SYM /_NN c_SYM (_( OX-_NNP 42_CD )_) at_IN a_DT 1_CD :_: 100_CD dilution_NN ._. Control_NN
          samples_NNS were_VBD incubated_JJ in_IN the_DT same_JJ manner_NN except_IN the_DT
          primary_JJ antibodies_NNS were_VBD omitted_VBN from_IN the_DT solution_NN ._. The_DT
          samples_NNS were_VBD rinsed_JJ quickly_RB in_IN PBS_NNP and_CC then_RB incubated_JJ for_IN
          30_CD minutes_NNS at_IN 37_CD °_NN C_NNP in_IN PBS_NNP containing_VBG the_DT secondary_JJ
          antibodies_NNS ,_, a_DT FITC-conjugated_NNP goat_NN anti-rabbit_JJ IgG_NNP at_IN a_DT
          dilution_NN of_IN 1_CD :_: 50_CD and_CC a_DT TRITC-conjugated_NNP goat_NN anti-mouse_JJ
          IgG_NNP at_IN a_DT dilution_NN of_IN 1_CD :_: 400_CD ._. The_DT samples_NNS were_VBD rinsed_JJ
          successively_RB in_IN PBS_NNP and_CC deionized_JJ water_NN and_CC then_RB were_VBD
          mounted_VBN on_IN glass_NN slides_NNS in_IN Aqua_NNP Polymount_NNP from_IN
          Polysciences_NNP ,_, Inc_NNP ._. (_( Warrington_NNP ,_, PA_NNP )_) ._. The_DT samples_NNS were_VBD
          allowed_VBN to_TO dry_VB in_IN the_DT dark_JJ and_CC were_VBD viewed_VBN using_VBG a_DT 100_CD ×_NN
          objective_NN lens_NN on_IN a_DT Nikon_NNP Eclipse_NNP E_NNP 400_CD epifluorescence_NN
          microscope_NN from_IN Nikon_NNP Inc_NNP ._. (_( Melville_NNP ,_, NY_NNP )_) ._. Digital_NN images_NNS
          of_IN the_DT cells_NNS were_VBD captured_VBN with_IN a_DT Spot_NNP 2_CD digital_JJ camera_NN
          from_IN Diagnostic_NNP Instruments_NNP ,_, Inc_NNP ._. (_( Sterling_NNP Heights_NNP ,_, MI_NNP )_)
          and_CC processed_VBN by_IN using_VBG the_DT Image-_NNP Pro_FW Plus_NNP image_NN analysis_NN
          computer_NN program_NN from_IN Media_NNP Cybernetics_NNP ,_, Inc_NNP ._. (_( Silver_NNP
          Spring_NNP ,_, MD_NNP )_) ._.
        
        
          Isolation_NNP and_CC culture_NN of_IN rat_NN neonatal_NN
          microglia_NN
          All_DT experiments_NNS were_VBD performed_VBN with_IN adherence_NN to_TO the_DT
          National_NNP Institutes_NNPS of_IN Health_NNP guidelines_NNS on_IN the_DT use_NN of_IN
          experimental_JJ animals_NNS and_CC with_IN protocols_NNS approved_VBN by_IN
          Midwestern_NNP University_NNP 's_POS Research_NNP and_CC Animal_NNP Care_NNP
          Committee_NNP ._. To_TO isolate_VB rat_NN neonatal_NN microglia_NN ,_, cerebral_JJ
          cortices_NNS of_IN 1_CD -_: 2_CD day-old_JJ Sprague-_NNP Dawley_NNP rats_NNS purchased_VBN
          from_IN Harlan_NNP (_( Indianapolis_NNP ,_, IN_IN )_) were_VBD surgically_RB removed_VBN
          and_CC placed_VBN in_IN cold_JJ DMEM_NNP +_NN 10_CD %_NN FBS_NNP +_NN 120_CD U_NNP /_NN ml_NN P_NN and_CC 12_CD
          μg_NN /_NN ml_NN S_NNP ,_, the_DT meninges_NNS carefully_RB removed_VBN ,_, and_CC brain_NN tissue_NN
          minced_JJ and_CC dissociated_JJ with_IN trypsin-_NN EDTA_NNP at_IN 36_CD °_NN C_NNP for_IN 3_CD -_: 5_CD
          min_NN ._. The_DT mixed_JJ glial_NN cell_NN suspension_NN was_VBD plated_JJ in_IN either_DT
          75_CD -_: or_CC 162_CD -_: cm_NN 2_CD vented_VBD cell_NN culture_NN flasks_NNS with_IN DMEM_NNP
          medium_NN supplemented_JJ with_IN 10_CD %_NN FBS_NNP +_NN 120_CD U_NNP /_NN ml_NN P_NN +_NN 12_CD μg_NN /_NN ml_NN S_NNP
          and_CC grown_VBN in_IN a_DT humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 36_CD °_NN C_NNP for_IN 12_CD -_: 14_CD days_NNS ._. On_IN
          day_NN 14_CD and_CC every_DT 3_CD -_: 4_CD days_NNS thereafter_RB ,_, microglia_NN were_VBD
          detached_VBN using_VBG an_DT orbital_NN shaker_NN (_( 150_CD rpm_NN ,_, 0_CD ._. 5_CD hours_NNS ,_,
          36_CD °_NN C_NNP ,_, 5_CD %_NN CO_NNP 
          2_LS )_) ,_, centrifuged_JJ (_( 400_CD ×_NN g_SYM ,_, 25_CD min_NN ,_,
          4_CD °_NN C_NNP )_) ,_, and_CC microglia_NN number_NN and_CC viability_NN assessed_VBN by_IN
          trypan_NN blue_JJ exclusion_NN ._. Microglia_NNP were_VBD characterized_VBN as_IN
          described_VBN earlier_JJR [_NN 7_CD ]_NN ._. Depending_VBG on_IN the_DT particular_JJ
          experimental_JJ protocol_NN (_( see_VB below_IN )_) ,_, microglia_NN averaging_VBG
          >_NN than_IN 95_CD %_NN viability_NN were_VBD plated_JJ in_IN either_DT 60_CD mm_NN ×_NN 15_CD
          mm_NN polystyrene_NN cell_NN culture_NN dishes_NNS ,_, 96_CD -_: well_RB cell_NN culture_NN
          clusters_NNS ,_, or_CC 24_CD -_: well_RB cell_NN culture_NN clusters_NNS ,_, with_IN DMEM_NNP
          supplemented_JJ with_IN 10_CD %_NN FBS_NNP +_NN 120_CD U_NNP /_NN ml_NN P_NN +_NN 12_CD μg_NN /_NN ml_NN S_NNP ,_, and_CC
          placed_VBD in_IN a_DT humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 36_CD °_NN C_NNP 18_CD -_: 24_CD hours_NNS prior_RB
          to_TO the_DT experiments_NNS ._.
        
        
          Primary_JJ culture_NN of_IN rat_NN cerebellar_NN granule_NN
          neurons_NNS
          Primary_JJ cultures_NNS of_IN rat_NN cerebellar_NN granule_NN neurons_NNS
          were_VBD prepared_VBN from_IN the_DT cerebella_NN of_IN 7_CD -_: day-old_JJ
          Sprague-_NNP Dawley_NNP rats_NNS ._. Cerebella_NNP were_VBD dissected_VBN and_CC
          processed_VBN as_IN described_VBN elsewhere_RB [_NN 61_CD ]_NN ._. The_DT dissociated_JJ
          cells_NNS were_VBD grown_VBN in_IN a_DT serum-free_JJ Neurobasal-_NNP A_DT medium_NN with_IN
          B_NNP 27_CD supplement_NN (_( 10_CD ml_NN /_NN 500_CD ml_NN )_) [_NN 62_CD ]_NN ,_, and_CC in_IN the_DT
          presence_NN of_IN 25_CD mM_NN KCl_NNP (_( Sigma_NNP )_) ._. The_DT cells_NNS were_VBD maintained_VBN
          in_IN poly-_NN L-_NNP lysine-treated_JJ (_( 10_CD ug_NN /_NN ml_NN ;_: Sigma_NNP )_) 96_CD -_: well_RB plates_NNS
          (_( 60_CD ,_, 000_CD cells_NNS /_NN 0_CD ._. 1_LS ml_NN Neurobasal_NNP A_DT medium_NN /_NN well_RB )_) ,_, at_IN 37_CD °_NN C_NNP
          in_IN an_DT incubator_NN with_IN 95_CD %_NN air_NN /_NN 5_CD %_NN CO_NNP 
          2_CD ._. This_DT method_NN results_NNS in_IN a_DT culture_NN
          consisting_VBG of_IN neuronal_NN precursors_NNS that_WDT differentiate_VB into_IN
          neurons_NNS ;_: the_DT differentiated_JJ cultures_NNS were_VBD used_VBN for_IN
          experiments_NNS after_IN 10_CD days_NNS ._.
        
        
          Experimental_NNP protocol_NN to_TO determine_VB the_DT viability_NN of_IN
          domoic_JJ acid-treated_JJ rat_NN neonatal_NN microglia_NN or_CC cerebellar_NN
          granule_NN neurons_NNS
          A_DT colorimetric_JJ assay_NN for_IN the_DT quantitation_NN of_IN cell_NN
          viability_NN ,_, based_VBN on_IN the_DT cleavage_NN of_IN the_DT tetrazolium_NN salt_NN
          WST-_NNP 1_CD
          (_( 4_CD -_: [_NN 3_CD -_: (_( 4_CD -_: Iodophenyl_NNP )_) -_: 2_CD -_: (_( 4_CD -_: nitrophenyl_NN )_) -_: 2_CD H-_NNP 5_CD -_: tetrazolio_NN ]_NN 1_CD ,_, 3_CD -_: benzene_NN
          disulfonate_NN )_) (_( slightly_RB red_JJ )_) to_TO formazan_NN (_( red_JJ )_) by_IN
          mitochondrial_NN dehydrogenases_NNS in_IN viable_JJ cells_NNS was_VBD utilized_JJ
          for_IN these_DT studies_NNS ._. Briefly_NNP ,_, rat_NN neonatal_NN microglia_NN or_CC
          cerebellar_NN granule_NN cells_NNS (_( 60_CD ,_, 000_CD cells_NNS /_NN well_RB )_) were_VBD
          plated_JJ in_IN LPS-free_NNP 96_CD -_: well_RB cell_NN culture_NN clusters_NNS 24_CD hours_NNS
          prior_RB to_TO the_DT experiments_NNS in_IN either_DT 0_CD ._. 1_CD ml_NN DMEM_NNP
          supplemented_JJ with_IN 10_CD %_NN FBS_NNP +_NN 120_CD U_NNP /_NN ml_NN P_NN +_NN 12_CD μg_NN /_NN ml_NN S_NNP
          (_( microglia_NN )_) ,_, or_CC 0_CD ._. 1_CD ml_NN serum-free_JJ Neurobasal_NNP A_DT medium_NN
          with_IN B_NNP 27_CD supplement_NN (_( cerebellar_NN granule_NN neurons_NNS )_) ._.
          Thereafter_RB each_DT well_RB received_VBN 4_CD μl_NN of_IN domoic_JJ acid_NN (_( 0_CD ._. 01_CD
          μM_NN -_: 1_CD mM_NN final_JJ concentration_NN )_) or_CC vehicle_NN (_( LPS-free_NNP
          water_NN )_) and_CC 10_CD μl_NN of_IN the_DT tetrazolium_NN salt_NN WST-obtained_NNP
          from_IN Roche_NNP Diagnostics_NNPS Gmbh_NNP (_( Mannheim_NNP ,_, Germany_NNP )_) ._. Plates_NNP
          were_VBD incubated_JJ in_IN a_DT humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 36_CD °_NN C_NNP and_CC the_DT reduction_NN
          of_IN the_DT WST-_NNP 1_CD reagent_NN to_TO formazan_NN was_VBD measured_VBN repeatedly_RB
          after_IN the_DT addition_NN of_IN the_DT WST-_NNP 1_CD reagent_NN ,_, at_IN either_DT 415_CD nM_NN
          (_( neurons_NNS )_) or_CC 450_CD nM_NN (_( microglia_NN )_) ,_, with_IN a_DT microtiter_NN plate_NN
          (_( ELISA_NNP )_) reader_NN ._.
        
        
          Experimental_NNP protocol_NN to_TO determine_VB the_DT effect_NN of_IN
          domoic_JJ acid_NN and_CC LPS_NNP on_IN rat_NN neonatal_NN microglia_NN release_NN of_IN
          TNF-α_NNP ,_, MMP-_NNP 2_CD ,_, MMP-_NNP 9_CD and_CC O_NNP 2_CD -_:
          To_TO study_VB the_DT time-dependent_JJ effects_NNS of_IN domoic_JJ acid_NN and_CC
          LPS_NNP on_IN the_DT generation_NN of_IN TNF-α_NNP ,_, MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD ,_, rat_NN
          neonatal_NN microglia_NN (_( 2_CD ._. 8_CD -_: 5_CD ×_NN 10_CD 6_CD cells_NNS /_NN 60_CD mm_NN ×_NN 15_CD mm_NN
          polystyrene_NN cell_NN culture_NN dish_NN )_) were_VBD treated_VBN with_IN (_( 1_LS )_) 1_CD mM_NN
          domoic_JJ acid_NN ,_, (_( 2_LS )_) LPS-free_NNP water_NN used_VBN as_IN a_DT vehicle_NN for_IN
          domoic_JJ acid_NN or_CC (_( 3_LS )_) 10_CD ng_NN /_NN ml_NN LPS_NNP in_IN a_DT final_JJ volume_NN of_IN 5_CD ml_NN
          of_IN DMEM_NNP supplemented_JJ with_IN 10_CD %_NN FBS_NNP +_NN 120_CD U_NNP /_NN ml_NN P_NN +_NN 12_CD μg_NN /_NN ml_NN
          S_NNP and_CC incubated_JJ in_IN a_DT humidified_JJ 5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 36_CD °_NN C_NNP for_IN 1_CD to_TO 6_CD h_NN ._. Upon_IN
          termination_NN of_IN the_DT experiments_NNS ,_, cell-free_JJ supernatants_NNS
          from_IN each_DT culture_NN dish_NN were_VBD assayed_JJ for_IN TNF-α_NNP ,_, MMP-_NNP 2_CD and_CC
          MMP-_NNP 9_CD ,_, while_IN rat_NN neonatal_NN microglia_NN were_VBD processed_VBN for_IN
          RNA_NNP isolation_NN and_CC RT-PCR_NNP ._. For_IN the_DT O_NNP 
          2_CD -_: assay_NN ,_, rat_NN neonatal_NN microglia_NN
          (_( 250_CD ,_, 000_CD cells_NNS /_NN 24_CD -_: well_RB cell_NN culture_NN clusters_NNS )_) were_VBD
          treated_VBN with_IN (_( 1_LS )_) 1_CD mM_NN domoic_JJ acid_NN ,_, (_( 2_LS )_) LPS-free_NNP water_NN
          used_VBN as_IN a_DT vehicle_NN for_IN domoic_JJ acid_NN or_CC (_( 3_LS )_) 10_CD ng_NN /_NN ml_NN LPS_NNP in_IN
          a_DT final_JJ volume_NN of_IN 1_CD ml_NN of_IN DMEM_NNP supplemented_JJ with_IN 10_CD %_NN FBS_NNP
          +_NN 120_CD U_NNP /_NN ml_NN P_NN +_NN 12_CD μg_NN /_NN ml_NN S_NNP and_CC incubated_JJ in_IN a_DT humidified_JJ
          5_CD %_NN CO_NNP 
          2_CD incubator_NN at_IN 36_CD °_NN C_NNP for_IN 1_CD to_TO 6_CD hours_NNS ._.
          Thereafter_RB the_DT media_NNS was_VBD removed_VBN ,_, 1_CD ml_NN warm_JJ HBSS_NNP was_VBD
          added_VBN ,_, and_CC rat_NN neonatal_NN microglia_NN were_VBD stimulated_VBN with_IN
          PMA_NNP [_NN 1_CD μM_NN ]_NN for_IN 120_CD min_NN and_CC O_NNP 
          2_CD -_: production_NN was_VBD assayed_JJ as_IN
          described_VBN below_IN ._.
        
        
          Experimental_NNP protocol_NN to_TO determine_VB the_DT effect_NN of_IN
          domoic_JJ acid_NN and_CC LPS_NNP on_IN rat_NN neonatal_NN microglia_NN TNF-α_NNP
          expression_NN :_: RNA_NNP isolation_NN and_CC semiquantitative_JJ RT-PCR_NNP
          analysis_NN
          Total_JJ rat_NN neonatal_NN microglia_NN RNA_NNP was_VBD isolated_VBN with_IN TRI_NNP
          reagent_NN purchased_VBN from_IN Molecular_NNP Research_NNP Center_NNP ,_, Inc_NNP ._.
          (_( Cincinnati_NNP ,_, OH_NNP )_) ._. The_DT RT-PCR_NNP were_VBD performed_VBN in_IN the_DT same_JJ
          sample_NN tube_NN using_VBG gene-specific_JJ primers_NNS obtained_VBN from_IN IDT_NNP
          (_( Coralville_NNP ,_, IA_NNP )_) ,_, as_IN described_VBN below_IN ,_, and_CC the_DT Superscript_NNP
          one-step_JJ kit_NN obtained_VBN from_IN Gibco-_NNP BRL_NNP (_( Grand_NNP Island_NNP ,_, NY_NNP )_) ._.
          Briefly_NNP ,_, first_JJ strand_NN cDNA_NN was_VBD made_VBN using_VBG 0_CD ._. 25_CD μg_NN of_IN RNA_NNP ,_,
          Superscript_NNP II_NNP H-_NNP reverse_VB transcriptase_NN ,_, antisense_NN
          gene-specific_JJ primers_NNS and_CC conditions_NNS of_IN 30_CD min_NN at_IN 50_CD °_NN C_NNP ._.
          Samples_NNP were_VBD denatured_JJ at_IN 94_CD °_NN C_NNP for_IN 2_CD min_NN ,_, and_CC PCR_NNP was_VBD
          performed_VBN for_IN various_JJ cycle_NN numbers_NNS to_TO ensure_VB linear_JJ
          amplification_NN ._. The_DT PCR_NNP cycling_NN conditions_NNS consisted_VBD of_IN a_DT
          denaturation_NN step_NN at_IN 94_CD °_NN C_NNP for_IN 30_CD s_VBZ ,_, an_DT annealing_VBG step_NN at_IN
          54_CD °_NN C_NNP (_( S_NNP 12_CD )_) or_CC 60_CD °_NN C_NNP (_( TNF-α_NNP )_) ,_, an_DT extension_NN step_NN at_IN 72_CD °_NN C_NNP for_IN
          1_CD min_NN ,_, and_CC a_DT final_JJ extension_NN step_NN at_IN 72_CD °_NN C_NNP for_IN 10_CD min_NN ._. The_DT
          50_CD μl_NN samples_NNS contained_VBD 0_CD ._. 2_CD mM_NN of_IN each_DT dNTP_NN ,_, 1_CD ._. 2_CD mM_NN
          magnesium_NN sulfate_NN ._. Platinum_NN ®_NN taq_NN DNA_NNP polymerase_NN ,_, and_CC 0_CD ._. 2_CD
          μM_NN of_IN each_DT gene_NN specific_JJ primer_NN ._. The_DT primers_NNS for_IN rat_NN
          TNF-α_NNP ,_, were_VBD designed_VBN using_VBG the_DT DNASTAR_NNP Lasergene_NNP software_NN
          (_( Madison_NNP ,_, WI_NNP )_) and_CC the_DT rat_NN TNF-α_NNP cDNA_NN sequence_NN (_( GenBank_NNP
          accession_NN number_NN NM_NNP 012675_CD )_) ,_, and_CC are_VBP sense_NN (_( bp_NN 127_CD -_:
          150_CD )_) :_: 5_CD '_POS -_: GGG_NNP GCC_NNP ACC_NNP ACG_NNP CTC_NNP TTC_NNP TGT_NNP CTA-_NNP 3_CD '_POS and_CC antisense_NN
          (_( bp_NN 285_CD -_: 307_CD )_) :_: 5_CD '_POS -_: CCT_NNP CCG_NNP CTT_NNP GGT_NNP TTG_NNP CTA_NNP CG-_NNP 3_CD '_POS ,_, and_CC
          generate_VB a_DT 181_CD bp_NN cDNA_NN product_NN ._. The_DT primers_NNS for_IN rat_NN
          constitutively_RB expressed_VBD ribosomal_JJ S_NNP 12_CD ,_, were_VBD sense_NN :_: 5_CD '_POS -_: ACG_NNP
          TCA_NNP ACA_NNP CTG_NNP CTC_NNP TAC_NNP A-_NNP 3_CD '_POS and_CC antisense_NN :_: 5_CD '_POS -_: CTT_NNP TGC_NNP CAT_NNP AGT_NNP
          CCT_NNP TAA_NNP C-_NNP 3_CD '_POS and_CC generate_VB a_DT 303_CD bp_NN cDNA_NN product_NN as_RB
          previously_RB described_VBD [_NN 63_CD ]_NN ._. Controls_NNP for_IN RT-PCR_NNP
          included_VBD samples_NNS without_IN the_DT enzyme_NN reverse_NN transcriptase_NN
          and_CC samples_NNS without_IN template_NN ._. The_DT PCR_NNP reactions_NNS were_VBD
          analyzed_VBN by_IN electrophoresis_NNS using_VBG 1_CD ._. 5_CD %_NN agarose_NN gels_NNS ,_,
          visualized_JJ with_IN SYBR_NNP ®_NN Gold_NNP nucleic_JJ acid_NN staining_VBG
          (_( Molecular_NNP Probes_NNP ;_: Eugene_NNP ,_, OR_NNP )_) ,_, photographed_VBN ,_, scanned_JJ and_CC
          digitized_JJ with_IN the_DT UN-SCAN-IT_NNP ™_NN gel_NN automated_VBN digitizing_VBG
          system_NN from_IN Silk_NNP Scientific_NNP (_( Orem_NNP ,_, UT_NNP )_) ._. The_DT relative_JJ
          amounts_NNS of_IN TNF-α_NNP expression_NN as_IN determined_VBN by_IN RT-PCR_NNP were_VBD
          normalized_JJ to_TO S_NNP 12_CD levels_NNS using_VBG methods_NNS similar_JJ to_TO those_DT
          previously_RB described_VBN by_IN others_NNS [_NN 64_CD ]_NN ._.
        
        
          Assays_NNP for_IN TNF-α_NNP and_CC O_NNP 2_CD -_: ._. TNF-α_NNP
          Immunoreactive_NNP TNF-α_NNP in_IN cell-free_JJ media_NNS supernates_NNS was_VBD
          determined_VBN using_VBG an_DT ultrasensitive_JJ rat-specific_JJ ELISA_NNP for_IN
          TNF-α_NNP purchased_VBD from_IN Biosource_NNP International_NNP (_( Camarillo_NNP ,_,
          CA_NNP )_) with_IN a_DT detection_NN limit_NN of_IN 0_CD ._. 7_CD pg_NN /_NN ml_NN ._. Results_NNS are_VBP
          expressed_VBN as_IN pg_NN /_NN ml_NN ._. 
          O_NNP 
          2_CD -_: :_: O_NNP 
          2_CD -_: generation_NN was_VBD determined_VBN by_IN the_DT
          SOD-inhibitable_NNP reduction_NN of_IN FCC_NNP [_NN 7_CD ]_NN ._. Briefly_NNP ,_, O_NNP 
          2_CD -_: release_NN from_IN microglia_NN was_VBD
          measured_VBN in_IN the_DT presence_NN of_IN FCC_NNP (_( 50_CD μM_NN )_) and_CC HBSS_NNP ,_, with_IN or_CC
          without_IN SOD_NNP (_( 700_CD Units_NNS )_) ._. All_DT experimental_JJ treatments_NNS were_VBD
          run_VBN in_IN triplicate_NN and_CC in_IN a_DT final_JJ volume_NN of_IN 1_CD ml_NN ._. Changes_NNS
          in_IN FCC_NNP absorbance_NN were_VBD measured_VBN at_IN 550_CD nm_NN using_VBG a_DT Beckman_NNP
          DU-_NNP 650_CD spectrophotometer_NN and_CC O_NNP 
          2_CD -_: generation_NN expressed_VBD in_IN nmol_NN by_IN
          employing_VBG the_DT molecular_JJ extinction_NN coefficient_NN of_IN 21_CD ._. 0_CD ×_NN
          10_CD 3_CD M_NNP -_: 1_CD cm_NN -_: 1_CD ._.
        
        
          SDS-PAGE_NNP gelatinase_NN zymography_NN for_IN MMP-_NNP 2_CD and_CC MMP-_NNP 9_CD
          analysis_NN
          Following_VBG incubation_NN with_IN LPS_NNP or_CC domoic_JJ acid_NN ,_, MMP_NNP
          expression_NN was_VBD analyzed_VBN in_IN the_DT harvested_VBN media_NNS of_IN
          cultured_JJ rat_NN neonatal_NN microglia_NN ._. As_IN the_DT rat_NN neonatal_NN
          microglia_NN cultures_NNS were_VBD normalized_JJ for_IN cell_NN number_NN ,_, equal_JJ
          volumes_NNS of_IN harvested_VBN media_NNS obtained_VBN from_IN each_DT condition_NN
          were_VBD analyzed_VBN ._. Briefly_NNP ,_, 10_CD μl_NN of_IN each_DT sample_NN were_VBD
          electrophoresed_JJ at_IN 4_CD °_NN C_NNP and_CC under_IN non-denaturing_JJ
          conditions_NNS using_VBG a_DT 10_CD %_NN polyacrylamide_NN gel_NN containing_VBG
          0_CD ._. 05_CD %_NN gelatin_NN ._. The_DT gels_NNS were_VBD incubated_JJ for_IN 1_CD hour_NN in_IN a_DT
          2_CD ._. 5_CD %_NN Triton_NNP X-_NNP 100_CD solution_NN and_CC then_RB washed_VBN twice_RB with_IN
          water_NN (_( 20_CD min_NN each_DT )_) ._. The_DT gels_NNS were_VBD then_RB incubated_JJ for_IN 24_CD
          hours_NNS at_IN 37_CD °_NN C_NNP in_IN 50_CD mM_NN Tris-_NNP HCl_NNP buffer_NN ,_, pH_NN 7_CD ._. 4_CD ,_,
          containing_VBG 5_CD mM_NN CaCl_NNP 
          2_CD ._. A_DT duplicate_JJ negative_JJ control_NN gel_NN
          was_VBD incubated_JJ as_IN described_VBN above_IN but_CC in_IN 50_CD mM_NN Tris-_NNP HCl_NNP ,_,
          pH_NN 7_CD ._. 4_CD containing_VBG 10_CD mM_NN EDTA_NNP instead_RB of_IN CaCl_NNP 
          2_CD ._. The_DT gels_NNS were_VBD fixed_VBN for_IN 1_CD hour_NN in_IN
          40_CD %_NN methanol_NN /_NN 7_CD %_NN acetic_JJ acid_NN and_CC then_RB stained_JJ in_IN
          Coomassie_NNP Blue_NNP Solution_NN (_( Sigma_NNP )_) ,_, followed_VBN by_IN destaining_VBG
          in_IN 10_CD %_NN methanol_NN ,_, 7_CD %_NN acetic_JJ acid_NN ._. MMP_NNP activity_NN was_VBD
          visualized_JJ as_IN clear_JJ bands_NNS against_IN a_DT blue_JJ background_NN ._.
          Gelatin-containing_NNP zymograms_NNS are_VBP typically_RB used_VBN to_TO detect_VB
          MMP-_NNP 2_CD (_( 72_CD kDa_NN )_) and_CC MMP-_NNP 9_CD (_( 92_CD kDa_NN )_) and_CC their_PRP$
          identification_NN is_VBZ based_VBN on_IN molecular_JJ weight_NN ._. Relative_NNP
          clearing_NN of_IN each_DT sample_NN was_VBD quantitated_JJ by_IN determining_VBG
          the_DT inverse_NN optical_JJ density_NN units_NNS using_VBG the_DT NIH_NNP Image_NN
          software_NN package_NN (_( version_NN 1_CD ._. 60_CD )_) ._. Values_NNP are_VBP represented_VBN
          as_IN the_DT mean_JJ ±_NN SE_NNP and_CC are_VBP presented_VBN as_IN inverse_NN optical_JJ
          density_NN ._. The_DT value_NN corresponding_JJ to_TO background_NN ,_, a_DT region_NN
          of_IN equal_JJ area_NN as_IN that_DT used_VBD to_TO measure_VB the_DT cleared_VBD bands_NNS
          and_CC of_IN a_DT lane_NN in_IN which_WDT no_DT sample_NN was_VBD loaded_VBN ,_, was_VBD
          subtracted_VBN from_IN each_DT sample_NN value_NN ._.
        
        
          Statistical_NNP analysis_NN of_IN the_DT data_NNS
          Data_NNP were_VBD analyzed_VBN with_IN the_DT Prism_NNP Rsoftware_NNP package_NN
          purchased_VBN from_IN GraphPad_NNP (_( San_NNP Diego_NNP ,_, CA_NNP ._. )_) ._. One_CD way_NN
          analysis_NN of_IN variance_NN followed_VBN by_IN Dunnett_NNP 's_POS test_NN was_VBD
          performed_VBN on_IN all_DT sets_NNS of_IN data_NNS ._. LPS_NNP or_CC domoic_JJ acid-treated_JJ
          groups_NNS were_VBD compared_VBN with_IN the_DT vehicle-treated_JJ group_NN ,_,
          shown_VBN as_IN 0_CD or_CC control_NN in_IN the_DT corresponding_JJ figures_NNS ._.
          Differences_NNS were_VBD considered_VBN statistically_RB significant_JJ at_IN
          p_NN <_NN 0_CD ._. 05_CD and_CC reported_VBD in_IN each_DT figure_NN legend_NN ._.
        
      
      
        Abbreviations_NNP
        AMPA_NNP ,_, α-amino-_JJ 3_CD -_: hydroxy-_NN 5_CD -_: methyl-_NN 4_CD -_: isoxazole_NN propionic_JJ
        acid_NN ;_: DMEM_NNP ,_, Dulbecco_NNP 's_POS modified_VBN Eagle_NNP medium_NN ;_: FBS_NNP ,_, fetal_JJ
        bovine_JJ serum_NN certified_VBN ;_: FCC_NNP ,_, ferricytochrome_NN c_SYM type_NN III_NNP ;_:
        HBSS_NNP ,_, Hank_NNP 's_POS balanced_JJ salt_NN solution_NN ;_: LPS_NNP ,_,
        lipopolysaccharide_NN ;_: MMP-_NNP 9_CD ,_, matrix_NN metalloproteinase-_NN 9_CD ;_: O_NNP 
        2_CD -_: ,_, superoxide_NN ;_: P_NN ,_, penicillin_NN ;_: PBS_NNP ,_,
        phosphate_NN buffered_JJ saline_NN ;_: PMA_NNP ,_, phorbol_NN 12_CD -_: myristate_NN
        13_CD -_: acetate_NN ;_: RT-PCR_NNP ,_, reverse_VB transcriptase_NN polymerase_NN chain_NN
        reaction_NN ;_: S_NNP ,_, streptomycin_NN ;_: SOD_NNP ,_, superoxide_NN dismutase_NN ;_:
        TNF-α_NNP ,_, tumor_NN necrosis_NNS factor_NN ._.
      
    
  
